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Abstract
Schizophrenia patients have altered neuronal connectivity, while the causal factor
is not fully understood. Most antipsychotic drugs possess dopamine D2 receptor
(D2R) antagonist property as a therapeutic target for reducing dopamine
hyperactivity in schizophrenia. It is, however, not known whether the blockage of
D2R is beneficial to neural connectivity. This study aimed to investigate the
mechanisms of neurite lesion induced by D2R overactivation and prevention of
such lesion by changing the D2R downstream signaling.
Disrupted in schizophrenia 1 (DISC1) is a genetic risk factor for a wide range of
psychiatric illnesses, including schizophrenia. DISC1 is a multifunctional scaffold
protein that regulates neurogenesis and neural development in the adult brain. The
excessive D2R-DISC1 complex is observed in the post-mortem brain of
schizophrenia patients. However, the role of D2R-DISC1 complex in neurite
outgrowth is unknown. The aim of Chapter 2 was to study whether neurite lesion
induced by D2R overactivation is through the D2R-DISC1 complex. This study
applied fluorescence resonance energy transfer (FRET) technique to quantify the
interaction between D2R and DISC1 in primary cortical neurons. D2R specific
agonist quinpirole increased the interaction of D2R and DISC1 by over activating
D2R in primary cortical neurons. Furthermore, the excessive D2R-DISC1 complex
reduced glycogen synthase kinase β (GSK-3β) phosphorylation. The increased
D2R-DISC1 complex formation in conjunction with the decreased GSK-3β
phosphorylation resulted in neurite impairment of cortical neurons. The
antipsychotics haloperidol and aripiprazole disrupted the excessive formation of the
D2R-DISC1 complex caused by D2R overactivation. However, only aripiprazole
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could reverse the downregulation of phosphorylated GSK3β caused by quinpirole.
Aripiprazole displayed better preventative effect than haloperidol on neurite lesion
induced by quinpirole, suggesting that aripiprazole and haloperidol may affect
neuroplasticity via different signaling pathways. Also, both haloperidol and
aripiprazole failed to rescue neurite lesion of primary cortical neurons from DISC1
mutant mice. In summary, the normal D2R-DISC1 complex signaling is critical for
neurite outgrowth.
Based on the results that the excessive D2R-DISC1 complex inhibited neurite
outgrowth, Chapter 3 aimed to determine whether and how the disruption of the
D2R-DISC1 complex affect the dendritic spines. This part of study applied a cellpenetrating peptide (TAT-D2pep), which could specifically disrupt the interaction
of D2R and DISC1 without blocking D2R itself. The super-resolution images
showed that the D2R-DISC1 complex existed in dendritic spines, neurites, and
soma of cultured striatal neurons. TAT-D2pep restored neurite length and spine
density to the normal level by separating the excessive D2R-DISC1 complex in
neurite and dendritic spines. In addition, this study revealed that uncoupling
excessive D2R-DISC1 complex could prevent neurite impairment via increasing
the expression of Neuropeptide-Y (NPY) in striatal interneurons. Taken together,
this study indicates that TAT-D2pep prevents the synaptic loss caused by the D2R
overactivation, suggesting that this cell-penetrating peptide is effective in treating
cognitive deficits in schizophrenia.
Oxidative stress is reported in the first episode of drug-naïve schizophrenia patients.
Although D2R hyperfunction is recognized in schizophrenia pathology, the
relationship between D2R overactivation and oxidative stress is unknown.
Therefore, Chapter 4 aimed to investigate whether and how D2R overactivation
2

affects mitochondrial reactive oxygen species (ROS) and ROS-mediated
mitophagy. Firstly, cryo-electron tomography (Cryo-ET) demonstrated that D2R
overactivation induced by quinpirole damaged cristae in mitochondria of cultured
striatal neurons. Notably, this study for the first time identifies D2R located on
neuronal mitochondria. Furthermore, overactivation of the membrane and
mitochondrial D2R exacerbated oxidative stress with increased ROS and
malondialdehyde (MDA). In addition, D2R overactivation caused incomplete
mitophagy. This study revealed that D2R overactivation could induce oxidative
stress and incomplete mitophagy.
In conclusion, these studies suggest that the neurite lesion induced D2R
overactivation is associated with excessive D2R-DISC1 complex formation and
oxidative stress. Thus, this study provides potential therapeutic targets for
alleviating neurite deficits in schizophrenia.
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Chapter One
1.1 General Introduction
Schizophrenia is a devastating mental illness that influences thought and behavior
(Howes et al., 2016). Neuroimaging findings have revealed that neurite deficits are
associated with cognitive symptoms in schizophrenia (Rae et al., 2017). The
hyperactivity of striatal D2R is predominantly responsible for psychosis in
schizophrenia, which leads the current antipsychotics to block D2R (Howes and
Kapur, 2009). However, the clinicians and researchers raise concerns about the
potential risks of antipsychotic side-effects due to the complete blockade of D2R.
Thus, there is a high urgency to understand the mechanism of D2R overactivation
induced neurite deficits. Although cAMP-dependent and β-arrestin independent
signaling pathways of D2R have been acknowledged as the principal downstream,
the exact mechanism is still largely unknown, especially for several identified D2Rheterocomplex. Furthermore, oxidative stress has recently been determined in the
first episode of drug-naïve schizophrenia patients with cognitive deficits (Solberg
et al., 2019, Xie et al., 2019). Therefore, D2R overactivation may regulate different
signaling pathways to affect neuroplasticity in the brain. The present series of Ph.D.
studies are designed to elucidate the mechanism of D2R overactivation in neurite
impairment and then discover proper atypical antipsychotics and cell-penetrating
peptides to prevent neurite lesions. A better understanding of these mechanisms
will help the development of new antipsychotic drugs to ameliorate neurite
impairment and oxidative stress with fewer side-effects for schizophrenia patients.

1.2 Literature Review
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1.2.1 Schizophrenia
Schizophrenia is a severe brain disorder that significantly impairs normal brain
function and the patients' response to reality (Karl and Arnold, 2014). There are
approximately 20 million people worldwide suffering schizophrenia at present
(Disease et al., 2018). Schizophrenia usually occurs in adolescent period and lasts
for a lifetime (Gomes et al., 2016). The symptoms of schizophrenia consisting of
positive symptoms such as delusions, hallucinations, negative symptoms such as
emotional flattening, social isolation, and cognitive symptoms such as learning
difficulties (Mueser et al., 2013). The actual pathology of schizophrenia remains to
be elucidated. Antipsychotic drugs are primary medications for treating
schizophrenia and other psychiatric disorders. If the patients suffer the first episode
of schizophrenia, the antipsychotics might treat them effectively (Girgis et al.,
2011). However, the absence of response to antipsychotics in certain patients and
their various side-effects, urging researchers to search for a better treatment for
schizophrenia.
1.2.2 D2R and Schizophrenia
The onset of psychotic symptoms is strongly associated with alterations in
dopamine function (Kesby et al., 2018). For healthy people, psychotic symptoms
can be induced by dopamine stimulants such as amphetamine. Positron emission
tomography findings report that elevated dopamine synthesis capacity and release
are observed in the striatum of schizophrenia patients compared with healthy
subjects (Howes et al., 2009). Alterations in dopaminergic function within the brain
are considered as a critical factor of psychotic symptoms (Winton-Brown et al.,
2014). Thus, striatal D2R antagonism is a general pharmacodynamic property of all
current antipsychotics, which further supports that D2R hyperactivity is a core
16

target for schizophrenia treatment (Urs et al., 2017). It is revealed that most
antipsychotics bind to D2R, but not D1R, and that blocking D2R is enough to inhibit
hyperdopaminergic activity (Beaulieu and Gainetdinov, 2011). Clinical studies
have confirmed that hyperdopaminergic activity occurs before the onset of
psychosis in schizophrenia, suggesting that the dysfunction of the dopaminergic
system is not the consequence of antipsychotic exposure or psychosis (Brisch et al.,
2014). Further, the occupancy of D2R above 80% could not only increase the risk
of cognitive decline but also extrapyramidal side effects (Sakurai et al., 2013).
Antipsychotic drug can cause extrapyramidal syndrome (EPS) including dystonia,
parkinsonism, and tardive dyskinesia. Thus, the evidence strongly supports that
D2R activity plays an essential role in psychosis.
1.2.3 D2R and Its Intracellular Signaling
The neurotransmitter dopamine belongs to the catecholamine family, having
various critical functional roles in humans, such as the regulation of voluntary
motor activity, cognition, and reward pathways (Kapur and Marques, 2016). The
effects of dopamine are mediated through five subtypes of dopamine receptors, D1
to D5. The dopamine D1-like receptor subtypes include the dopamine D1 and D5
receptors, whereas the D2-like receptor subtypes consist of dopamine D2, D3, and
D4 receptors (Rangel-Barajas et al., 2015). Generally, the D1R and D2R distribute
more widely than the D3R, D4R, and D5R in the brain (Hurley and Jenner, 2006,
De Mei et al., 2009). There are two major D2R alternatively spliced isoforms, D2Rlong isoform (D2RL) and D2R-short isoform (D2RS), which are distinguished by
the additional 29 amino acids of the third intracellular loop (ICL3) (Giros et al.,
1989). It has been reported that D2RL majorly represents in postsynapse, while
D2RS expresses in pre-synapse and is associated with auto-receptor functions (De
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Mei et al., 2009). The D2R is richly expressed in the striatum, nucleus accumbens,
and frontal cortex. Further, D2R is also shown in the ventral tegmental area,
hypothalamus, and hippocampus (Seeman, 2006).
D2R is a G protein-coupled receptor (GPCR) that activates both G proteindependent signaling and non-G protein cascades (Beaulieu et al., 2009). Activation
of the D2R can inhibit the activity of adenylyl cyclase after it couples to Gαi
proteins (Bergson et al., 2003). D2R is also demonstrated to modulate other second
messengers, including inositol phospholipid, arachidonic acid, potassium, and
calcium currents (Missale et al., 1998). Notably, D2R can function not only through
cAMP levels but also through the noncanonical Akt-GSK3 signaling cascade
triggering by recruiting β-arrestin proteins (Beaulieu et al., 2005, Beaulieu et al.,
2007). Thus, it is crucial to study which one of D2R signaling pathways is targeted
by antipsychotic drugs.
1.2.4 Dual Role of D2R in Neurite Outgrowth
Neuronal development involves morphological alterations of neurite to become
functional axons and dendrites (Ronan et al., 2013). Dopamine and its D2R are
associated with neuronal development. Researchers started to investigate the effects
of D2R activation on neurite outgrowth from dopamine. Decades ago, dopamine
was firstly reported to elongate neurite through activating D2R in embryonic rat
cortical neurons (Reinoso et al., 1996). Later, some researchers performed studies
to investigate the outcomes of modulating D2R activity on neuronal morphology in
vitro and in vivo. Cortical neuroplasticity is found to be another target of
antipsychotics by blocking D2R activity (Rangel-Barajas et al., 2015). Todd et al.
firstly reported treatment with 10 to 1000 nM quinpirole resulted in small increases
in the average length of neurites in primary cortical neurons. The effects on
18

branching did not reach statistical significance. These two morphogenic effects
were blocked by D2R antagonists eticlopride and spiperone, suggesting a low
concentration of quinpirole promotes neurite growth via D2R (Todd, 1992).
Following this critical finding, Todd's group transfected D2-like receptors (D2, D3
and D4) into the dopaminergic mesencephalic cell line MN9D, which confirmed
the role of D2R overexpression in inhibiting neurite outgrowth (Swarzenski et al.,
1994). At that time, psychiatric disorders are considered that the dopaminergic
pathways are overactive (Seeman, 1987). Thus, researchers are interested in
whether D2R overactivation will alter the neuronal morphology. Reinoso et al.
reported that quinpirole at 1 µM promotes neurite outgrowth, which is consistent
with previous findings. However, they also firstly demonstrated that quinpirole at
100 µM significantly inhibited neurite length and branch of cultured rat cortical
neurons (Reinoso et al., 1996). Previous researches suggest that D2R plays a role
in neuronal differentiation and neurogenesis. Combined with previous clinical
research, this finding links the D2R overactivation to neuronal impairment and
cognitive decline in psychiatric disorders. Therefore, this thesis aimed to
investigate the mechanism underlying neuronal impairment caused by D2R
overactivation.
1.2.5 Overactivation of D2R Causes Synaptic Loss
The synaptic reduction is the critical pathology in schizophrenia. The two wellestablished observations support this opinion. First, the progressive loss of gray
matter was observed in patients at the time of disease onset (Vita et al., 2012).
Second, significant reductions in the density of dendritic spines on pyramidal
neurons of schizophrenia patients were observed (Moyer et al., 2015). A recent
study revealed that dendritic spines with smaller volumes were significantly lost in
19

the post-mortem brain of schizophrenia patients, suggesting the inhibition of
synaptogenesis exists in schizophrenia (MacDonald et al., 2017). Importantly,
previous findings demonstrated that the synaptic loss in the prefrontal cortex is not
the consequence of treatment with antipsychotic medications (Glantz and Lewis,
2000). Animal studies offer in vivo evidence to reveal the importance of D2R in
regulating dendritic spines. Chronic treatment with a selective D2R agonist PPHT
decreased the spine density of cortical pyramidal neurons without affecting
GABAergic interneurons. D2R may directly mediate the inhibition of dendritic
spines by PPHT existed in pyramidal neurons, but also indirectly through D2R of
interneurons (Castillo-Gomez et al., 2016). However, another study shows that
quinpirole increased the dendritic spine density in hippocampal neurons, suggesting
that the effects of D2R on the dendritic spine could also be concentrationdependent. Jia et al. thoroughly investigated the function of D2R in dendritic spine
morphogenesis by using pharmacologic and genetic approaches (Jia et al., 2013).
The dendritic spine density of hippocampal neurons was significantly reduced after
male mice were intraperitoneally injected with D2R agonists quinpirole and
bromocriptine. Continuous injection of eticlopride remarkably enhanced the spine
density, whereas the single injection failed to do so. Interestingly, D1R is not
involved in regulating hippocampal spine development. Besides, overexpression of
D2R reduced the spine density of CA1 hippocampal neurons, whereas knockdown
of D2R increased it (Jia et al., 2013).
It is believed that the abnormal neurodevelopment in schizophrenia can lead to
improper function of synaptic communication (Harrison and Weinberger, 2005). A
variety of proteins exists in synapses, which have been used as biomarkers of
synaptic connection. Synaptophysin is widely used as the marker of presynapse,
20

which can also indicate neuronal synaptic density (Okabe et al., 2001). The
expression of synaptophysin in the cortex is significantly declined in patients with
schizophrenia (Osimo et al., 2019). PSD-95 is abundant in the brain and
concentrated in the postsynaptic density. In human post-mortem studies, PSD-95
expressed at a relatively low level in brain regions, which may be associated with
cognitive decline in schizophrenia (de Bartolomeis et al., 2014). Another postmortem study reported that adolescent schizophrenia patients had reduced
expression of PSD-95 protein in the thalamus and hippocampus (Clinton and
Meador-Woodruff, 2004, Toro and Deakin, 2005). PSD-95 was reported to interact
with other synaptic proteins, such as DISC1, in the development of excitatory
synapses as well as in regulating synaptic strength and plasticity (Seshadri et al.,
2015). Taken together, it is important to investigate the mechanisms underlying the
inhibitory effects of D2R overactivation on synapse in this thesis.
1.2.6 Overactivation of D2R Causes Cognitive Decline
The neurocognitive decline is a core feature in schizophrenia patients (Simpson et
al., 2010). Accumulating evidence has shown that the dopaminergic system in the
central nervous is profoundly associated with cognition. Using single-photon
computerized emission tomography, Abi-Dargham et al. found that the increased
occupancy of striatal D2 receptors by dopamine occurs in first-episode drug-naive
patients. Notably, the occupancy of striatal D2R is not statistically different
between drug-naïve and previously treated patients (Kegeles et al., 2008). Thus, the
increased activation of D2 receptors by dopamine observed in schizophrenia
patients is present at the onset of illness and not a consequence of antipsychotic
treatment. A recent study reported that decreased D2R occupancy by aripiprazole
intervention contributed to cognitive improvement in schizophrenia patients (Shin
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et al., 2018). To further investigate the role of D2R in specific aspects of cognition,
a murine model of schizophrenia was generated featuring with D2R
overexpression. Mice overexpressing D2R in the striatum displayed a significant
deficit in working memory instead of a general cognitive deficit (Kellendonk et al.,
2006). However, whether or not there is an impaired working memory caused by
D2R overactivation in adolescence is still unknown.
1.2.7 DISC1 Regulates Neurodevelopment
Among all potential candidate genes, DISC1 is considered as one of the most
convincing risk factors for major mental disorders. Initial evidence for the
involvement of the DISC1 gene in schizophrenia is mainly based on a large Scottish
pedigree where the gene is disrupted by a chromosomal translocation (Millar et al.,
2000). There are two remarkable expression peaks of DISC1 during neurogenesis
in the developing mouse brain, suggesting that its crucial role in neurodevelopment
(Schurov et al., 2004). The pathology of DISC1-related psychiatric disorders is
because of an altered interaction between DISC1 and other proteins. Therefore,
identifying the novel interactors with DISC1 will be of great importance in
understanding the therapeutic target for treating schizophrenia.
The researchers have demonstrated that DISC1 plays an essential role in neuronal
development and maturation by utilizing the DISC1 mutation mice model. In the
DISC1 transgenic model, mice have shown schizophrenia-like phenotypes,
including deliberated neuronal morphology, lowered neuron density, diminished
neurogenesis, and reduced striatal volumes (Clapcote et al., 2007, Lee et al., 2011).
In human brains, DISC1 has a robust modulatory effect on cortical development
and increases the thickness of the prefrontal cortex (Carless et al., 2011). Seeman
proposed that D2R is in a high-affinity state (D2Rhigh) in schizophrenia, suggesting
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the activity of D2R could be the target for treatment instead of blocking the D2R
(Seeman et al., 2006). Results from the animal research exhibited that DISC1 can
increase the proportion of D2Rhigh in the striatum, which led to the status of
dopamine hyperactivity (Jaaro-Peled et al., 2013). In addition, it was reported that
DISC1 dysfunction increased dopamine receptors in the striatum without altering
the dopamine level in the DISC1-L100P mutant (Clapcote et al., 2007).
DISC1 contributes to the proliferation of neural progenitors through the interaction
with GSK3 and, in turn, regulation of β-catenin activity (Mao et al., 2009, Singh et
al., 2011). DISC1 directly inhibited GSK3β activity, which prevented the
phosphorylation and degradation of β-catenin (Mao et al., 2009). Furthermore,
knockdown of DISC1 inhibited progenitor proliferation, which is likely through
exiting the premature cell cycle. These effects could be restored by overexpression
of β-catenin or reducing GSK3β activity (Mao et al., 2009, Singh et al., 2011).
DISC1 is mainly located in dendritic spines in which relates to the synaptic
architecture (Hayashi-Takagi et al., 2010). In the mature mouse brain, DISC1
determines the development of functional synapses and the rate of transduction of
intrinsic excitability (Kim et al., 2012). Besides, DISC1 mice with point mutant on
Gln31Leu and Leu100Pro showed a significantly decreased spine density (Lipina
et al., 2013), indicating that synapse alternation may link to their behavioral
phenotypes. This study aimed to reveal how the DISC1 would interact with its
associated proteins in the synapse to regulate dendritic spine formation.
1.2.8 A Novel Antipsychotic Target: D2R-DISC1 Complex
Accumulating data indicate that D2R is a hub receptor that interacts not only with
many G protein-coupled receptors but also with scaffolding proteins (Bradshaw
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and Porteous, 2012). One emerging new concept in neuropsychopharmacology is a
dysfunction of D2R complexes contributing to the development of schizophrenia.
The role of D2R in schizophrenia pathology has altered with the discovery of
various D2R complexes in the brain. These D2R complexes may offer novel targets
for antipsychotic drugs and provide better therapeutic outcomes.
Recent research showed the hyperdopaminergic status induces an increase of D2RDISC1 complex, and this complex is also found in the post-mortem brain from
schizophrenia patients and mouse models of schizophrenia (Su et al., 2014). Based
on these findings, a new compound targeted on interfering D2R-DISC1 interaction
with less antipsychotic-like side effects is synthesized (Su et al., 2014). The
achievement of antipsychotic-like outcomes only needs interrupting the interaction
between D2R and DISC1 without blocking D2R completely. The D2R-DISC1
complex is an important finding because it narrows down the targets of
antipsychotics, which may avoid side-effects. However, whether the D2R-DISC1
complex plays a role in neuroplasticity is unclear, which will be investigated in this
study. Furthermore, it will be essential to identify the location of the D2R-DISC1
complex in neurons by using high-resolution microscopy. Dysfunction of the
scaffolding protein can cause alternations of protein complexes. Thus, this study
also utilizes DISC1-LI mice, which diminishes the D2R-DISC1 binding site, to
elucidate the role of DISC1 in neuroprotection.
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Figure 1.1 Diagram of the human D2R sequence. Sequence highlighted with red
represents D2R-DISC1 interacting site (211aa-225aa). TAT-D2pep will bind to the
D2R-DISC1 interacting site to separate the D2R-DISC1 complex. Sequence
highlighted with blue represents the difference between D2R long isoform and D2R
short isoform. It illustrates that both D2R long isoform and D2R short isoform can
interact with DISC1. Abbreviation: ECL: extracellular loop; ICL: intracellular loop;
TM: transmembrane.
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1.2.9 GSK-3 Converges D2R and DISC1 Intracellular Signaling Pathway
Several studies have implicated that GSK-3β is associated with the symptoms of
neuropsychiatric disorders like schizophrenia (Lovestone et al., 2007). The
phosphorylation of GSK-3β on serine 9 indicates the inhibited activity of GSK-3
(Grimes and Jope, 2001). Recent studies have shown that not only atypical
antipsychotics but also typical antipsychotics increases the phosphorylation of
GSK-3α and GSK-3β by either activating Akt or mimic Akt activity (Li and Xu,
2007, Park et al., 2011a). It is indicated that cAMP levels in neurons do not regulate
the effect of D2R on GSK-3β activity. Instead, it is modulated by a multifunctional
scaffolding protein β-arrestin, which is known to be responsible for G proteincoupled receptor internalization (Beaulieu et al., 2007). The D1R agonist
SKF38393 does not alter GSK-3β phosphorylation at serine 9, suggesting that
GSK-3β phosphorylation may be regulated explicitly by D2R (Lebel et al., 2009).
The regulation of D2R on GSK-3 is further determined by using D2R knockout
mice. The absence of hippocampal D2R leads to neuronal apoptosis by increasing
the activity of GSK-3β in the mice (Tripathi et al., 2010). D2R knockout mice
showed delays in movement initiation and inhibition in total locomotor activity,
implicating that the abnormal behavior induced by D2R may arise through GSK-3
activation (Kelly et al., 1998). There were no significant increases in
phosphorylated CaMKIIα in neurons of nucleus accumbens shell and caudate
nucleus of D2 knockout mice, suggesting that calcium signaling cascade was not
involved in D2R signaling pathway (Rashid et al., 2007).
DISC1 is shown to determine the proliferation and fate of neural progenitors
through interaction with GSK-3 and regulation of β-catenin activity (Mao et al.,
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2009, Singh et al., 2011). DISC1 directly inhibits GSK-3β activity, which prevents
the phosphorylation and degradation of β-catenin (Mao et al., 2009). Knocking
down DISC1 gene expression inhibits neuronal progenitor proliferation while overexpression of DISC1 rescues neurodevelopment in the developing cortex (Niwa et
al., 2010). The inhibited neuronal proliferation can also be restored by overexpression of β-catenin or inhibiting GSK-3β activity (Mao et al., 2009, Singh et
al., 2011). Furthermore, reduced progenitor proliferation is possibly due to exiting
the premature cell cycle. In addition, the enhanced occupancy of D2R was observed
in the striatum of DISC1 mutant (dominant-negative) mice, suggesting that the
activation of GSK-3β induced by dysfunctional DISC1 may be through D2R
overactivation (Jaaro-Peled et al., 2013).
Although GSK-3β knockout mice could die in utero, GSK-3β heterozygous
knockout mice are viable and display decreases in exploratory activity and reduced
locomotor activity to amphetamine (Urs et al., 2012). GSK-3α knockout mice are
viable and exhibited a reduction in locomotion to a new environment and impaired
sensorimotor gating (Kaidanovich-Beilin et al., 2009). Because GSK3β signaling
is vital in promoting neurite outgrowth and activated GSK3β is associated with the
development of psychosis, it is assumed that the GSK3β signaling pathway is
involved in the D2R-DISC1 complex intracellular signaling (Beurel et al., 2015).
1.2.10 NPY Modulates Neurite Outgrowth
Neuropeptide Y (NPY) is a vital neuromodulator which is richly existed in the
central nervous system (Gotzsche and Woldbye, 2016). More recently, we
addressed the question of whether NPY is involved in the haloperidol-induced
neuronal impairment. In our laboratory, it was found that the downregulation of
NPY caused by haloperidol results in dendritic spine loss and neuronal damage in
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primary striatal neurons. The short-chain fatty acid propionate protected against
neuronal lesions by upregulating the NPY level (Hu et al., 2018). Treatment with
quinpirole or amphetamine decreased NPY expression by overactivation of D2R in
mice (Kuo, 2003). Previously, Hansel et al. revealed that NPY is identified in the
immature neurons and precursor cells of the rat brain, suggesting its function in
neurogenesis (Hansel et al., 2001). NPY-deficient mice contain about 25% fewer
neurons than wild type mice, indicating loss of NPY in vivo inhibits the
development of neuronal progenitors (Hansel et al., 2001). Accumulating pieces of
evidence regarding the study of striatal NPY indicated that the existence of a
possible reciprocal relationship between D2R and NPY. This study aimed to
investigate the effect of D2R-DISC1 complexes on NPY.
1.2.11 Mechanism of Haloperidol on Neurite Impairment
Antipsychotic drug modulates dysfunction in neurotransmission, which plays an
important role in reducing the symptoms of schizophrenia (Huang and Song, 2019).
Substantial evidence has suggested that neuronal plasticity exhibited by neurite
outgrowth and neuroprotection underlies the therapeutic effects of atypical
antipsychotic drugs (Lieberman et al., 2008, Molteni et al., 2009). As a
representative first-generation antipsychotic drug (FGA), haloperidol antagonizes
D2R to reduce positive symptoms with little effect on cognitive improvement
(Harvey et al., 2005). Further, the neurotoxic effects of haloperidol have been
reported to cause side effects, including extrapyramidal symptoms and tardive
dyskinesia (Rasmussen et al., 2017). The blockade of striatal D2R is believed to be
responsible for haloperidol drawbacks (Kapur et al., 2000). So far, the effect of
neurotoxicity of haloperidol has been compared with several second-generation
antipsychotic drugs. Haloperidol has neurotoxicity in SH-SY5Y cells by increasing
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caspase-3 activity (Gasso et al., 2012). Our group recently reported that haloperidol
impaired neurite growth of human SH-SY5Y neurons and primary striatal neurons
through down-regulating NPY expression (Hu et al., 2018). Notably, we found that
haloperidol prevented the reduction of neurite length induced by D2R
overactivation but no change in the number of branching in primary cortical
neurons. Haloperidol had no significant effects on reversing synaptophysin and
PSD-95 expression in the cortical neurons treated with quinpirole (Zheng et al.,
2018). It has been demonstrated that haloperidol had no effects on promoting
neurite growth and upregulating synaptic proteins compared with amisulpride,
which is an atypical antipsychotic drug. They demonstrated that haloperidol failed
to protect neuronal morphology mainly because it does alter BDNF expression and
GSK-3β phosphorylation in human neuroblastoma cells (Park et al., 2011b). Other
researchers found that haloperidol decreases the synaptophysin expression in the
rat hippocampus (Lieberman et al., 2008). However, the expression of
synaptophysin was not significantly changed in the primate cerebral cortex (Lidow
et al., 2001). Thus, it is imperative to investigate why haloperidol cannot protect
neurite and improve cognition in this thesis.
1.2.12 Mechanism of Aripiprazole on Neuronal Protection
Binding to D2R is considered as a necessary action for current antipsychotic drugs
(Kapur et al., 2000). However, there is a clear distinction in the D2R binding
affinity between FGAs and second-generation antipsychotics (SGAs). FGAs
majorly antagonize D2R, while SGAs can bind to other membrane receptors with
less D2R occupancy (Lieberman et al., 2008). Moreover, the pharmacological
findings of aripiprazole have changed the understanding of antipsychotic action on
dopamine receptors. Research on aripiprazole provides a clinically relevant
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mechanism according to D2R occupancy instead of the D2R blockade. Depending
on endogenous dopamine levels, aripiprazole may act as a full antagonist or a
partial agonist on D2R (de Bartolomeis et al., 2015). Unlike FGAs, aripiprazole is
effective in reducing positive symptoms and improving cognitive function (Kumar
et al., 2017). More importantly, aripiprazole may pose a lower risk of
extrapyramidal symptoms and relapse (Kane et al., 2007, Kane et al., 2002).
Compared with haloperidol, aripiprazole is clinically proven to have superior
efficacy and safety in the treatment of early-stage schizophrenia (Girgis et al.,
2011). Besides, several pharmacological studies have revealed that aripiprazole
possesses neuroprotective features. We report that aripiprazole ameliorates neurite
impairment caused by D2R overactivation in cultured cortical neurons (Zheng et
al., 2018). Ishima et al. also found that aripiprazole potentiates NGF-induced
neurite outgrowth of PC 12 cells (Ishima et al., 2012). Similar to aripiprazole,
another D2R partial agonist brexpiprazole is also reported to promote neurite
outgrowth in conjunction with NGF in PC 12 cells, suggesting that the property of
agonism could contribute to neuroplasticity (Ishima et al., 2015). Aripiprazole
protects dopaminergic neurons against glutamate cytotoxicity, which can be
blocked by D2R antagonist sulpiride (Matsuo et al., 2010). Aripiprazole is also
reported to prevent synaptic loss, which is associated with the treatment of
pathology of schizophrenia (Glausier and Lewis 2013). Compared with haloperidol
treatment, the administration of aripiprazole significantly increases dendritic spine
density with a rise in postsynaptic puncta (Takaki et al., 2018). Several pieces of
research have contemporarily highlighted that the neuroprotective effect of
aripiprazole is mediated by Akt-GSK3 signaling cascade (Pan et al., 2016, Takaki
et al., 2018, Park et al., 2009). Although some atypical antipsychotic drugs, like
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olanzapine or ziprasidone, have been revealed to promote neurite outgrowth
through upregulating synaptophysin and PSD-95 expression, the investigation of
aripiprazole on these synaptic proteins has not yet been performed. Since
aripiprazole acts as a partial agonist of D2R, it is necessary to investigate whether
the D2R-DISC1 complex and its downstream signaling pathway are affected by
aripiprazole.
1.2.13 Super-resolution Technique to Reveal Synaptic Composition
Stochastic Optical Reconstruction Microscopy (STORM) is one of the most
commonly used types of super-resolution microscopy. STORM has made it
possible to break the diffraction barrier and reveal objects as small as 10-20 nm
(Bates et al., 2013). Particularly exciting is the possibility of imaging the very early
stages of spine formation and subsequent maturation, which has not been possible
to study with conventional light microscopy. Additionally, the molecular
composition and organization of synapses are essential for synaptic plasticity. The
enhanced resolution of STORM permits a more precise analysis of protein
localization and interaction within individual spines and synapses (Rust et al., 2006,
Hruska et al., 2018). Previous research using the STORM technique has reported
that clozapine may restore dendritic spine density by changing the number of D2R
nanoclusters in the striatum of the mice model mimicking schizophrenia (Onishi et
al., 2018). Our preliminary research showed that D2R activity is vital to strengthen
synaptic plasticity (Hu et al., 2018, Zheng et al., 2018). However, we were unable
to observe and quantify D2R within synapse due to a lack of nanoscale microscopy.
Interestingly, a recent study reported that as the size of a dendritic spine increases,
there is a net increase in the amount of PSD-95 and synaptophysin found in a single
dendritic spine (Hruska et al., 2018). So far, it has not been revealed how the D2R
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interacts with DISC1 in a single synapse. By applying STORM to observe dendritic
spines of cultured neurons, this study aimed to study the interaction of D2R and
DISC1 and its effects on synaptic connections from a nanoscale perspective.
1.2.14 Schizophrenia and Oxidative Stress
The brain is particularly vulnerable to oxidative damage (Gandhi and Abramov,
2012). Clinical data indicated that the risk factors converge upon oxidative stress
in schizophrenia patients (Koga et al., 2016). The occurrence of oxidative stress
adversely impacts the developmental brain, which is relevant to the development
of schizophrenia. Oxidative stress occurs when there is an overproduction of
reactive oxygen species. The oxidative stress in schizophrenia leads to
mitochondrial damage, which drives mitochondria to produce more oxidants
(Rajasekaran et al., 2015). Several studies have demonstrated that mitochondrial
malfunction can lead to cellular degeneration (Dias et al., 2013). The degeneration
is because the peroxidation of membrane lipids produces toxic aldehydes, which
can impair critical mitochondrial enzymes (Murphy, 2009). Notably, a study using
a combined transcriptomic, proteomic, metabolic approach found that altered
proteins in schizophrenia patients are associated with mitochondrial function and
oxidative stress responses (Prabakaran et al., 2004). Abnormal mitochondrial
morphology, size, and density have been reported in the brains of schizophrenia
individuals (Ben-Shachar, 2002). An increased level of oxidative stress was
reported in the first episode of drug-naïve schizophrenia patients with cognitive
deficits (Solberg et al., 2019, Xie et al., 2019). Clinical study also showed an
increased lipid peroxidation, particularly in first-episode drug naïve patients with
schizophrenia (Jordan et al., 2018). Ketamine and phencyclidine are often used to
induce psychotic symptoms. These psychostimulants increase the ROS as part of
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their mechanism of action (Kovacic and Cooksy, 2005). When the ROS inhibitor
NAC was given to schizophrenia patients, it ameliorated the symptoms even in
treatment-resistant patients (Zhang and Yao, 2013). Thus, ample evidence suggests
a vital role for oxidative stress in the pathogenesis and progression of
schizophrenia.
1.2.15 Neurite Lesion Induced by D2R Overactivation via Oxidative Stress
Neurons are well-known to be vulnerable to ROS-induced damage. ROS causes
neurite lesions before the induction of cell death (Fukui, 2016). Neuron produces
ROS at multiple organelles. Among these sites, mitochondria contribute to the most
substantial amount of ROS. The production of mitochondrial ROS is primarily
through the release of superoxide at complexes I and III of the mitochondrial
respiratory chain (Murphy, 2009). Thus, mitochondrial integrity is essential for
maintaining normal ROS level and neuronal morphology. Mitochondrial injury has
been documented to result in neurite impairment. Firstly, mitochondrial integrity is
fundamental to the formation of the neural network. Fragmented mitochondria and
distorted cristae enhance mitochondrial ROS formation, reduce ATP levels, and
show a severely disrupted neural network (Ganjam et al., 2019). Permeabilization
of the mitochondrial membrane significantly upsurges oxidative stress, followed by
the loss of hippocampal neurons in mice (Merkwirth et al., 2012). Secondly, the
amount

of

mitochondrial

is

associated

with

neurite

outgrowth.

Immunocytochemistry results showed that the growing neurite of cortical neurons
contains more active mitochondria, especially at the terminal of neurite (Trigo et
al., 2019). Recent research revealed that excessive mitochondrial ROS production
decreases mitochondrial number and motility, followed by neurite impairment in
M17 human neuroblastoma cells (Parrado-Fernandez et al., 2018). Although
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conventional electron microscopy provides us strong evidence about the alternation
of mitochondria in neuronal impairment, the sample preparation is redundant, and
sometimes it can cause structural damage. Using cryo-electron tomography (cryoET), this study aimed to examine whether D2R overactivation would cause neurite
lesion through affecting mitochondrial in native environments within axons and
synaptic vesicles of primary neurons.
A wide range of studies has reported that ROS inhibits neurite outgrowth.
Excessive ROS production significantly decreases the percentage of cells with
neurite outgrowth to 5% within 24 hours in N2a cells (Wang et al., 2010). Damaged
neurites of N2a cells tend to become bead-shaped or fragmented (Fukui, 2016). The
ROS specific inhibitor NAC blocks the axonal lesion caused by oxidative stress
(Hervera et al., 2018). NAC can inhibit nerve growth factor-induced neurite
outgrowth of PC12 cells by decreasing ROS amount, suggesting the dual role of
ROS on neurites (Zhou and Too, 2011, Suzukawa et al., 2000). In addition, a high
level of ROS significantly decreases the density of the dendritic spine, which has
been documented in patients, animal models and cell models (Massaad and Klann,
2011). Thus, the effect of ROS on neurite outgrowth still requires further
investigation.
The role of D2R in regulating ROS is debatable. Accumulating evidence showed
that excessive endogenous or exogenous dopamine increased ROS production in
the brain (Delcambre et al., 2016). The excessive ROS production induced by
dopamine could cause cell death in SH-SY5Y cell line (Gomez-Santos et al., 2003).
The early study revealed that primary cortical neurons treated with dopamine had
significantly increased ROS production, which was blocked by D2R antagonists
(Grima, 2003, Acquier et al., 2013). Blocking ROS production by D2R antagonist
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also alleviates huntingtin-induced death of striatal neurons (Charvin et al., 2005).
Therefore, this study aimed to determine whether oxidative stress is involved in the
reduced neurite outgrowth induced by D2R overactivation.
1.2.16 Targeting Mitophagy as Novel Strategy for Treating Neurite Deficits
Basal autophagy activity is critical to the maintenance of neuronal homeostasis and
viability (Klionsky and Emr, 2000). Human cells have sophisticated regulatory
pathways to maintain mitochondrial homeostasis through balanced mitochondrial
biogenesis and clearance of damaged mitochondria. Mitophagy, a form of
autophagy, mediates the removal of defective mitochondria (Lou et al., 2019).
Neuronal autophagy also plays essential roles during neuronal development, for
example, axon outgrowth and synapse formation (Tomoda et al., 2019). Mitophagy
is crucial for protecting cells against the deleterious effects of damaged
mitochondria (Yamada et al., 2019, Fang et al., 2019). In postmitotic neurons, the
autophagosomes are continuously formed at the distal end of the axon and undergo
transportation along microtubules toward the soma, which is enriched with
lysosomes to clear unnecessary materials (e.g., amino acids, lipids) (Ashrafi et al.,
2014). A recent study further showed that macroautophagic activity within the
learning and memory center is responsible for synaptic plasticity by maintaining
the expression of NPY in drosophila (Bhukel et al., 2019).
Disruptions in neuronal autophagy contribute to the pathophysiology of
neuropsychiatric disorders (Tomoda et al., 2019). The SQSTM1 (also known as
p62) is an autophagy substrate that is used as a reporter of autophagy activity (Liu
et al., 2016). SQSTM1 is decreased when autophagy is induced while it is
accumulated when autophagy is inhibited; therefore, SQSTM1 may be used as a
biomarker to study the autophagic process (Bjørkøy et al., 2009). As elevated
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SQSTM1 expression is found in the prefrontal cortex of schizophrenia patients, the
autophagy-deficiency caused by hyperdopaminergic may be associate with
SQSTM1 expression. One study reported that D2R knockdown inhibited
autophagic influx, suggesting D2R is a positive regulator of autophagy (Wang et
al., 2018). Recently, Aveleira and colleagues have shown that NPY can initiate
autophagy in the hypothalamic neuronal cell line, as shown by the analysis of
LC3B-II turnover, the decrease of SQSTM1 and the increase in the number of
autophagosomes and autolysosomes (Aveleira et al., 2015). The research on D2R
induced neuronal autophagy will also help us to have a greater level of
understanding in the signaling pathway involving D2R-NPY-autophagy.
Interestingly, quinpirole decreases cell viability without initiating neuronal
autophagy (Leng et al., 2017). Thus, whether and how D2R activation regulates
mitophagy is still largely unknown. A better understanding of D2R and mitophagy
might provide new therapeutic targets for the treatment of schizophrenia.
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1.3 Aims and Hypothesis
1.3.1 Specific Aims
The aims of this research were to:
1. Study whether and how the excessive D2R-DISC1 complex formation affects
neurite outgrowth, D2R intracellular signaling, and synaptic proteins in the primary
neurons.
2. Evaluate the effects of haloperidol and aripiprazole on D2R-DISC1 complex
formation and neuroprotection.
3. Determine the neuroprotective effects of novel antipsychotic peptide TATD2pep and mechanisms underlying its protection in primary the striatal neurons.
4. Investigate the effects of D2R overactivation on oxidative stress and mitophagy
in the primary striatal neurons.
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1.3.2 Hypothesis
1. The excessive D2R-DISC1 complex caused by D2R specific agonist quinpirole
will decrease the phosphorylation of Akt-GSK3β, which will lead to the reduction
of neurite growth and dendritic spine density. Furthermore, quinpirole will decrease
the expression of synaptic proteins, indicating that the increased interaction
between D2R and DISC1 will also cause synaptic loss.
2. Aripiprazole may have better protection on neuronal morphology than
haloperidol.
3. TAT-D2pep will protect neurite outgrowth and dendritic spine formation by
specifically decreasing D2R-DISC1 complex formation.
4. Overactivation of intracellular and mitochondrial D2R will cause oxidative stress
and incomplete mitophagy.
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1.3.3 Significance
Schizophrenia influences approximately 20 million people throughout the world.
Antipsychotic drugs are the primary medication for the treatment of schizophrenia
as well as other psychiatric disorders. Nevertheless, the absence of response to
antipsychotics in certain patients, along with their various side-effects, driving
researchers to find a better treatment for schizophrenia. D2R antagonism is a
general pharmacodynamic property of all current antipsychotics, which further
supports that D2R hyperactivity is a core target for schizophrenia treatment. In
addition, clinical and pre-clinical findings have indicated that neurite deficits are
associated with schizophrenia featured by cognitive decline. Synaptic loss is
considered as the critical phenotype of schizophrenia. Previous findings
demonstrate that the reduction of dendritic spines in the brain is not the
consequence of treatment with antipsychotic medications. Thus, investigating the
effects of D2R overactivation on neuronal impairment, and antipsychotic drugs
target which signaling pathway of D2R, will contribute to understanding the
mechanisms of D2R overactivation induced neurite lesion from several interrelated
perspectives. Comparing the effects of haloperidol and aripiprazole on
neuroprotection will help us have a better understanding of the features of atypical
and typical antipsychotic drugs.
The dysfunction of D2R complexes in schizophrenia subjects is a promising target
in neuropsychopharmacology. These D2R complexes could offer novel targets for
antipsychotic drugs and provide better therapeutic outcomes. The excessive D2RDISC1 complex was recently identified in the post-mortem brain from
schizophrenia patients and mouse models of schizophrenia. However, the role of
the D2R-DISC1 complex in neuroplasticity is still unclear. The findings in this
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thesis will provide evidence of whether the cell-penetrating peptide TAT-D2pep
targeting on the D2R-DISC1 complex has neuroprotective effects. In addition,
oxidative stress has been recently determined in the first episode of drug-naïve
schizophrenia patients with cognitive deficits. Elucidating the effects of D2R
overactivation caused oxidative stress on neurite outgrowth will provide another
important mechanism underlying neurite deficits. Results from the current study
may offer evidence for developing new antipsychotic drugs targeting on
ameliorating cognitive decline for schizophrenia patients.
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1.4 General Methods
1.4.1 Antibodies and Chemicals
The reagents used in this thesis are summarized in Table 1.4.1.
Table 1.4.1 Summary of Materials in the Thesis
Reagent

Source

Identifier

Mouse monoclonal anti-D2R

Santa Cruz

sc-5303

Mouse monoclonal anti-GAD67

Millipore

MAB5406

Mouse monoclonal anti-CaMKII-α

Cell Signaling

50049

Mouse monoclonal anti-β-actin

Millipore

MAB1501

Mouse monoclonal anti-MAP2

Sigma

M4403

Mouse monoclonal anti-

Sigma

SAB4502906

Mouse monoclonal anti-PSD-95

Invitrogen

516900

Mouse monoclonal anti-

Sigma

SAB4502906

Rabbit monoclonal anti-Akt Ser473

Cell Signaling

4060

Rabbit monoclonal anti-Akt Thr308

Cell Signaling

13038

Rabbit monoclonal anti-Akt (pan)

Cell Signaling

4685

Rabbit monoclonal anti-GSK3α/β

Cell Signaling

5676

Rabbit monoclonal anti-GSK3β

Cell Signaling

5558

Rabbit monoclonal anti-NPY

Sant Cruz

sc-133080

Rabbit monoclonal anti-DISC1

Abcam

EPR14684

Donkey anti-mouse Alexa Fluor 488

Invitrogen

A21202

Donkey anti-rabbit Alexa Fluor 568

Invitrogen

A10042

Goat anti-rabbit Alexa Fluor 488

Invitrogen

A11008

Goat anti-mouse Alexa Fluor 568

Invitrogen

A11004

Donkey anti-goat Alexa Fluor 647

Invitrogen

A21447

Donkey anti-rabbit Alexa Fluor

Invitrogen

A37573

Donkey anti-mouse Alexa Fluor

GE Healthcare

1301

Quinpirole hydrochloride

Sigma

Q102

Haloperidol

MP Biomedical

11403062

Aripiprazole

Sigma

SML0935

Antibodies

Chemicals and Peptides
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Continued
TAT-D2pep*

GeneScript

N/A

TAT-D2pep-NC

GeneScript

N/A

Cell Light™ Actin-RFP, BacMam

Invitrogen

C10583

Phalloidin Alexa Fluor 568

Invitrogen

A12380

Neurobasal® Medium

Thermofisher

21103049

B27 Supplement

Thermofisher

17504044

ProLong™ Diamond Antifade

Thermofisher

P36961

DL-2-Amino-5-

Sigma

A5282

Trypsin inhibitor

Sigma

T9253

Poly-D-Lysine

Sigma

P7280

REDExtract-N-Amp™ Tissue PCR

Sigma

XNAT

TAE Buffer (Tris-acetate-EDTA)

Sigma

B49

Donkey serum

Sigma

D9663

D2R-eGFP

GeneScript

N/A

DISC1-mCherry

GeneScript

N/A

D2R mutation-eGFP

GeneScript

N/A

D2R-Flag

Sino Biological

HG12111

Primary cortical neurons

C57BL/6J (ABR)

N/A

Primary cortical neurons

DISC1

(JHU)

N/A

Primary striatal neurons

C57BL/6J (ABR)

N/A

HEK-293 cells

ATCC

CRL1573

Recombinant DNA

Experimental Models:

Abbreviations: ABR: Australian BioResources; JHU: Johns Hopkins University.
*The design of TAT-D2pep was based on the region from K211 to T225
(KIYIVLRRRRKRVNT) of D2R, which was known to directly interact with
DISC1 (Su et al., 2014, Lipina et al., 2018). The molecular weight and purity of
TAT-D2pep were analyzed by high-performance liquid chromatography (HPLC)
and mass spectrometry (MS) before it was applied in experiments.
1.4.2 Cortical and Striatal Neuron Culture
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All experimental procedures were approved by the Animal Ethics Committee,
University of Wollongong, Australia, and complied with the Australian Code of
Practice for the Care and Use of Animals for Scientific Purposes. Dissociated
mouse cortical (Chapter 2) and striatal cultures (Chapter 3 and Chapter 4) were
prepared as previously described from postnatal 0 to 3-day-old C57BL/6J, or
DISC1-LI mice described previously (kindly provided by Prof. A. Sawa, Johns
Hopkins University School of Medicine) (Shahani et al., 2015, Seshadri et al.,
2015). To generate DISC1-LI mice, the exon1-3 and Δ25bp on Exon 6 of DISC1
are deleted. Heterozygous DISC1-LI male and wild-type C57BL/6J female mice
were mated to obtain heterozygous DISC1-LI and wild type pups. Genotypes were
carried out by tail snipping and polymerase chain reaction prior to tissue collection
at PN0. Briefly, cortical or striatal cells were gently dissociated with a plastic
pipette after digestion with 0.5% trypsin (GIBCO, Los Angeles, USA) at 37°C for
30 min. Cells were cultured in Neurobasal medium (GIBCO) containing B27
supplement (GIBCO), 1M glucose (only for culturing cortical neurons) and 20mM
glutamine (Sigma Aldrich). After 24 hours of culture, Cultures were maintained at
37°C in a humidified 5% CO2 incubator and used for experiments at seven days in
vitro. The half volume of the culture medium was changed twice a week. The final
concentration of quinpirole used in this study was optimized based on its effect on
the neurite length of cortical or striatal neurons, and the data was acquired by a
Lionheart FX Automated Microscope (BioTek Instruments, Winooski, Vermont,
USA).
1.4.3 HEK-293 Cell Culture and Transfection
HEK-293 cells were grown in DMEM (Life Technologies, Carlsbad, USA)
containing 10% fetal bovine serum and 1% penicillin-streptomycin (Thermo
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Fisher, Waltham, USA) at 37°C in 5% CO2. On the day before transfection, the
culture medium was changed to DMEM containing 10% fetal bovine serum without
penicillin-streptomycin. The D2R-EGFP, D2R mutant-EGFP, and DISC1-mCherry
coding sequences were synthesized by GenScript (GenScript, Hong Kong Ltd) and
sub-cloned into the pcDNA3 vector. To obtain the D2R mutant-EGFP, the
sequence coding the DISC1 binding site, KIYIVLRRRRKRVNT, was deleted from
the full sequence of the D2R long isoform. The D2R-Flag plasmid is from Sino
Biological Incorporation (Beijing, China). Transfection was performed using
Lipofectamine 2000 (Life Technologies) according to the manufacturer’s
instructions. After 24 hours of transfection, cells were treated with different drugs.
1.4.4 Immunofluorescence
Cells for immunofluorescence were plated on 13 mm coverslips coated with 0.1
μg/ml poly-d-lysine (Sigma Aldrich) at a final concentration of 1.0 × 105 cells/well.
Following treatment, cells were fixed in 4% freshly-made formaldehyde,
permeabilized with 0.3% Triton X-100/phosphate buffered saline (PBS), and
blocked with 5% normal donkey serum (Sigma Aldrich) in PBS. Cells were first
immunostained with primary antibodies overnight and then with secondary
antibodies for 2 hr. Cells were viewed using a 63× oil immersion objective on a
DMI6500B confocal microscope or DMi8 fluorescence microscope (Leica,
Mannheim, Germany). The neurite length and branches were measured by
manually tracing the neurites using ImageJ software (Rasband, W.S., ImageJ, U. S.
National Institutes of Health, Bethesda, Maryland, USA, https://imagej.nih.gov/ij/,
1997-2016).
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1.4.5 Fluorescence Resonance Energy Transfer (FRET)
Confocal FRET analysis was performed as described previously (Hasbi et al.,
2009). In the cortical neurons, anti-D2R-Alexa Fluor 488 was used as a donor
dipole, while anti-DISC1-Alexa Fluor 568 was used as an acceptor dipole. In HEK293 cells, D2R-GFP was used as a donor dipole, while DISC1-mCherry was used
as an acceptor dipole. The donor was excited with an argon laser at 488 nm, while
the acceptor was excited with a DPSS laser at 568 nm. Samples were analyzed
using the Leica application wizard for FRET sensitized emission.
1.4.6 Western Blot
After treatment, cells were immediately collected in lysis buffer containing NP40
(Sigma Aldrich), protease inhibitor cocktail (Sigma Aldrich), 1 mM
phenylmethylsulfonyl fluoride (Sigma Aldrich) and 0.5 mM β-glycerophosphate
(Sigma Aldrich). Total protein concentrations were determined by the DC-Assay
(BioRad, Hercules, USA), and detected using a SpectraMax Plus384 absorbance
microplate reader (Molecular Devices, Sunnyvale, USA). The sample protein was
separated on SDS-PAGE gels and then transferred onto polyvinylidene fluoride
(PVDF) membranes. Incubation with primary antibodies was performed overnight
at 4 °C. The blots were then washed and incubated with secondary antibodies for 2
hours at room temperature. For visualization, immunoreactivity was detected using
enhanced chemiluminescence detection reagents. The blots were scanned with an
Amersham Imager 600 RGB (GE Health, Chicago, USA), and densitometry
analysis was performed with ImageQuant TL 8.1 Software (GE Health, Chicago,
USA).
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1.4.7 Super-resolution Imaging of D2R and DISC1 in Dendritic Spines
Primary striatal neurons for STORM imaging were plated on µ-slide 8 well glass
bottom plates (Ibidi, Martinsried, Germany). Endogenous D2R and DISC1 were
fixed, cells were permeabilized and immunolabelled by primary and secondary
antibodies conjugated with Cy3B-NHS and Alexa 647-NHS, respectively, as
previously described (Du et al., 2016). An imaging buffer (100 mM Tris/HCl pH
8.0, 20 mM NaCl and 10% glucose, all from Sigma-Aldrich) and an oxygen
scavenger system (60 mg/ml glucose oxidase and 6 mg/ml catalase, both from
Sigma-Aldrich) were used for STORM imaging (Wang et al., 2015) and 140 mM
β-mercaptoethanol was added to promote photo-switching. Two-color STORM
imaging was sequentially acquired for up to 50,000 frames under the excitation of
647 nm and 561 nm lasers at a power density of 3~5 kW/cm2 and under the photoactivation of a 405 nm laser (Coherent Inc.) with a power density of 0.5 kW/cm2
at the sample. STORM image analysis, nearest neighbor distances calculation, drift
correction, image rendering, protein nanocluster identification, quantification and
image presentation were performed using Insight3 (a gift from Prof. Bo Huang at
UCSF), custom-written Matlab (2012a, MathWorks) codes, SR-Tesseler (IINS,
Interdisciplinary Institute for Neuroscience), and Image J (Image Processing and
Analysis in Java).
1.4.8 Cell preparation for cryo-EM
Carbon-coated gold TEM grids (Quantifoil NH2A R2/2) were performed plasma
cleaning at 2 mA for 10 seconds. Grids were sterilized under UV three times for
30 min at room temperature. Grids were carefully washed twice in PBS and coated
with 0.1 μg/ml poly-d-lysine for 1 hour at 37 °C. After three PBS washes, striatal
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neurons were plated on a final concentration of 3.0 x 105 cells/grid. For cell
vitrification, live striatal neurons were blotted from the backside of the grid for 9 s
and rapidly frozen in liquid nitrogen using a Leica EMGP system.
1.4.9 Image acquisition by Cryo-electron microscopy
Cryo-ET was performed on a Tecnai 20 equipped with a field emission gun and
operated at 200 kV (Thermo Fisher company). Images were captured using either
Explore 3D or SerialEM software on a 4k x 4k camera (Ultrascan from Gatan) and
a Falcon II (FEI, Thermo Fisher) direct electron detector, with a 14 μm pixel size.
Tilt series of mitochondria were acquired covering an angular range of - 60° to +
60° with a 2 to 4 degrees increment. All tilt series were acquired at magnifications
of 25,000× or 29,000 ×, binning 2. Tomograms were manually segmented with the
program AMIRA (FEI).
1.4.10 Statistical analysis
GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA) was used to
calculate the significance between groups. Shapiro-Wilk test was used to examine
if the data were normal distribution. Levene’s test of equality of error variances was
performed to check the data for homogeneity of variance. The t-test was used to
analyze the significant difference between the two groups. One-way ANOVA was
performed for comparing the mean values of multiple groups, followed by Tukey’s
post hoc test. Data were expressed as means ± SEM and p < 0.05 was considered
statistically different.
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1.5 Overview of the Thesis
Schizophrenia is a severe mental disorder featured with impaired neuronal
connections in the brain. All the current antipsychotic drugs target on D2R to
counterbalance its hyperactivity associated with psychotic symptoms. However, the
neurite deficits in the majority of schizophrenia are not ameliorated by current
antipsychotic drugs. Thus, it is of great importance to understand the mechanism
of D2R overactivation caused neurite deficits, which will provide evidence in
developing the novel antipsychotic drugs. The phenotypes of the primary cortical
and striatal neurons have been demonstrated to be relevant to the cortex and
striatum in vivo. This study applied the primary neurons to investigate the
mechanism of neurite impairment and evaluate the effects of antipsychotic drugs.
Furthermore, the super-resolution technique facilitates us to observe the pattern of
existence of interested proteins and the interaction of proteins within a single
dendritic spine of neurons. This study highlights the significance of the D2RDISC1 complex as well as oxidative stress in neuroplasticity. These findings
contribute to developing novel antipsychotic drugs to treat neurite deficits and
decrease oxidative stress with fewer side effects.
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1.5.1 Aripiprazole and haloperidol protect neurite lesions via reducing
excessive D2R-DISC1 complex formation
D2R hyperactivity causes altered brain development and later produces onset of
symptoms mimicking schizophrenia. It is known that D2R interacts with DISC1;
however, the effect of D2R-DISC1 interaction in intracellular signaling and neurite
growth has not been studied. This study investigated the effect of D2R overactivation on Akt-GSK3β signaling and neurite morphology in cortical neurons.
Over-activation of D2Rs caused neurite lesions, which were associated with
decreased Akt and GSK3β phosphorylation in cortical neurons. The antipsychotic
drug aripiprazole was more effective in the prevention of neurite lesions than
haloperidol. Unlike haloperidol, aripiprazole prevented downregulation of pAktpGSK3β induced by D2R hyperactivity, indicating the involvement of different
pathways. D2Rs were hyperactive in cortical neurons of mice with DISC1
mutation, which caused more severe neurite lesions in cortical neurons treated with
quinpirole. Immunofluorescent staining for CaMKII confirmed that cortical
pyramidal neurons were involved in the D2R hyperactivity-induced neurite lesions.
Using the FRET technique, we provide direct evidence that D2R hyperactivity led
to D2R-DISC1 complex formation, which altered pGSK3β signaling. This study
showed that D2R hyperactivity-induced D2R-DISC1 complex formation is
associated with decreased pAkt-pGSK3β signaling and, in turn, caused neurite
impairment. Aripiprazole and haloperidol prevented the impairment of neurite
growth but appeared to do so via different intracellular signaling pathways.
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1.5.2 Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor
Overactivation in Striatal Neurons
Psychosis has been considered a disorder of impaired neuronal connectivity.
Evidence for excessive formation of D2R-DISC1 complexes has led to a new
perspective on molecular mechanisms involved in psychotic symptoms. Here, we
investigated how excessive D2R-DISC1 complex formation induced by D2R
agonist quinpirole affects neurite growth and dendritic spines in striatal neurons.
Fluorescence resonance energy transfer, stochastic optical reconstruction
microscopy, and cell penetrating-peptide delivery were used to study the cultured
striatal neurons from mouse pups. Using these striatal neurons, our study showed
that: (1) D2R interacted with DISC1 in dendritic spines, neurites and soma of
cultured striatal neurons; (2) D2R and DISC1 complex accumulated in clusters in
dendritic spines of striatal neurons and the number of the complex were reduced
after application of TAT-D2pep; (3) uncoupling D2R–DISC1 complexes by TATD2pep protected neuronal morphology and dendritic spines; and (4) TAT-D2pep
prevented neurite and dendritic spine loss, which was associated with restoration
of expression levels of synaptophysin and PSD-95. In addition, we found that NPY
and GSK3β were involved in the protective effects of TAT-D2pep on the neurite
spines of striatal spiny projection neurons. Thus, our results may offer a new
strategy for precisely treating neurite spine deficits associated with schizophrenia.
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1.5.3 Overactivation of Mitochondrial Dopamine D2 Receptor Inhibits
Mitophagy
Oxidative stress has been recently observed in the first episode of drug-naïve
schizophrenia patients. Although D2R dysfunction has long been recognized in
schizophrenia pathology, whether it can affect mitochondrial ultrastructure and
ROS-mediated mitophagy are largely unidentified. Here, we investigated how D2R
over-activation inhibits ROS-initiated mitophagy and working memory in mice.
Cryogenic electron microscopy (Cryo-EM) and schizophrenia mice model were
used in this study. Our findings showed that (1) D2R overactivation caused by
quinpirole reduced number and length of cristae in mitochondria of cultured striatal
neurons; (2) D2R located on neuronal mitochondria; (3) D2R specific agonist
quinpirole exacerbated oxidative stress with increased ROS and malondialdehyde
(MDA) in primary striatal neurons; (4) SQSTM1 expression was up-regulated by
quinpirole suggesting the mitophagy was inhibited; (5) Administration of
quinpirole caused working memory impairment and stereotyped behavior in adult
mice. Therefore, these findings may provide a new strategy for alleviating oxidative
stress associated with schizophrenia.
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1.5.4 Summary
In summary, D2R overactivation caused neurite lesion is associated with excessive
D2R-DISC1 complex formation and incomplete mitophagy. This study for the first
time discovers that the unbalanced interaction between D2R and DISC1 result in
reductions in neurite outgrowth and dendritic spine formation. This study also
examined the alternation of the D2R intracellular signaling pathway, which is
associated with the neuroplasticity. The excessive formation of the D2R-DISC1
complex decreased the phosphorylation of GSK-3β in cortical and striatal neurons.
D2R overactivation also downregulated the NPY expression level, while disrupting
D2R-DISC1 complex caused by D2R overactivation restored the NPY level to
normal. Besides the impairment in neuronal morphology, this study also reported
the inhibited synaptic connections caused by increased interaction of D2R and
DISC1.
By comparing the effects of haloperidol and aripiprazole on neuroplasticity, the
findings showed that aripiprazole had better protection on neurite length than
haloperidol. Aripiprazole could increase the expression level of phosphorylated
GSK3β, whereas haloperidol had no effects on GSK3β phosphorylation. Using
DISC1 mutant mice, this study also demonstrated that haloperidol and aripiprazole
prevented neurite impairment through DISC1. In addition, this study first identified
that both haloperidol and aripiprazole could block the quinpirole-induced
interaction of D2R and DISC1 in cultured cortical and striatal neurons. This thesis
has also firstly reported that TAT-D2pep disrupted the interaction between D2R
and DISC1 to prevent neurite lesions, suggesting this complex would be a potential
therapeutic approach for treating neurite deficits.
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Protein-protein interactions exist in the synapse to affect synaptic architecture and
neurotransmission. Here, STORM images revealed that both D2R and DISC1
existed within synapse in a nanocluster pattern instead of a single molecular. The
cell-penetrating peptide TAT-D2pep separated the complex of D2R and DISC1 in
synapses, suggesting that this peptide with antipsychotic-like effects may be
capable of strengthening synaptic plasticity. Interestingly, the diameter of D2R and
DISC1 nanoclusters was not changed by quinpirole or TAT-D2pep. This study for
the first time reports the relationship between the actual distance of proteins and
FRET occurrence, which is the first time that FRET has been elucidated from a
nanoscale perspective.
Finally, this study reported that oxidative stress and incomplete mitophagy were
involved in the neurite lesion caused by D2R overactivation. Cryo-EM has been
the dominant technique to observe fine structures, like mitochondrion, inside the
neuronal synapse. The current study observed that D2R overactivation damaged
mitochondrial cristae, suggesting that the importance of D2R in controlling
mitochondrial integrity. Furthermore, this study for the first time reveals the
existence of D2R on the mitochondrial membrane. Overactivation of mitochondrial
D2R remarkably stimulates mitochondrial ROS production. Understanding D2R
subcellular localization can actively contribute to receptor function and even
disease pathology. This study also demonstrated that mitophagy inhibition might
be another mechanism

underlying

membrane and

mitochondrial

D2R

overactivation.
Taken together, these findings have provided extensive new knowledge on the
mechanism of D2R in regulating neuroplasticity. The TAT-D2pep could be a new
drug for treating schizophrenia, especially with neurite deficits.
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Chapter Two
Aripiprazole and Haloperidol Protect Neurite Lesions via Reducing Excessive
D2R-DISC1 Complex Formation
Reprinted from Progress in Neuro-Psychopharmacology & Biological Psychiatry,
92, Zheng, Peng, Minmin Hu, Yuanyi Xie, Yinghua Yu, Hanna Jaaro-Peled, and
Xu-Feng Huang. Aripiprazole and haloperidol protect neurite lesions via reducing
excessive D2R-DISC1 complex formation, 59-69, Copyright (2019), with
permission from Elsevier.
Available at:
https://doi.org/10.1016/j.pnpbp.2018.12.007
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Fig. S2 Genetic background of DISC1-LI mice. To generate DISC1-LI mice,
the exon1-3 and Δ25bp on Exon 6 of DISC1 are deleted. aa: amino acid.
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Chapter Three
Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor
Overactivation in Striatal Neurons
Reprinted from Frontiers in Neuroscience, 14, Peng Zheng, Qian Peter Su, Dayong
Jin, Yinghua Yu, and Xu-Feng Huang. Prevention of Neurite Spine Loss Induced
by Dopamine D2 Receptor Overactivation in Striatal Neurons, 642, Copyright
(2020), with permission from Frontiers.
Available at:
https://doi.org/10.3389/fnins.2020.00642
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Chapter Four
Overactivation of Dopamine D2 Receptor Inhibits Mitophagy
Abstract
Oxidative stress has been recently observed in the first episode of drug-naïve
schizophrenia patients. Although D2R dysfunction has long been recognized in
schizophrenia pathology, whether it can affect mitochondrial ultrastructure and
reactive oxygen species (ROS)-mediated mitophagy are unknown. Here, this study
determined if D2R overactivation by quinpirole affects mitochondrial ultrastructure
in cultured primary striatal neurons by cryo-electron tomography (Cryo-ET). The
oxidative stress, mitophagy, and neurite outgrowth were further examined in
quinpirole-treated neurons. The present study showed that (1) quinpirole decreased
number and length of cristae in mitochondria of cultured striatal neurons; (2) D2R
located on neuronal mitochondria; (3) D2R specific agonist quinpirole exacerbated
oxidative stress with increased ROS and malondialdehyde (MDA) in primary
striatal neurons; and (4) SQSTM1 expression was up-regulated by quinpirole
suggesting the mitophagy process was inhibited. Altogether, this study indicates
that D2R overactivation inhibits oxidative stress-induced mitophagy deficit, which
may be involved in neurite impairment. The identification of mitochondrial D2R
provides a new target for treating neurite lesions.
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4.1 Introduction
Schizophrenia is a complex mental disorder influenced by genetic and
environmental factors; however, the underlying pathological mechanisms are
mostly unknown (Howes et al., 2016). Oxidative stress has recently been identified
in the first episode of drug-naïve patients with schizophrenia and cognitive deficits
(Solberg et al., 2019, Xie et al., 2019). Another study also observed increased lipid
peroxidation, particularly in first-episode drug naïve patients with schizophrenia.
These findings suggest that oxidative stress is involved in the pathogenesis and
progression of schizophrenia (Jordan et al., 2018).
D2R dysfunction has long been reported in schizophrenia and psychiatric disorders
(Kostrzewa et al., 2018). Striatal D2R upregulation is frequently documented in
schizophrenia patients without antipsychotic treatment history (Kubota et al., 2017).
Recent pharmacological studies involving antipsychotics highlighted how D2R
signaling could regulate mitochondrial ROS production (Anglin et al., 2012). A
growing list of mitochondrial G-protein coupled receptors (GPCR) have also been
linked with mitochondrial ROS production and include the 5-HT4 receptor (Wang
et al., 2016), cannabinoid CB1 receptors (Benard et al., 2012), and melatonin MT1
receptors (Ahluwalia et al., 2018). The existence of D2R in neuronal mitochondria
has not yet been confirmed, although past studies showed that administration of the
D2R agonists, quinpirole and dopamine, could directly affect mitochondrial
functions (Brenner-Lavie et al., 2008). Besides the well-known functions of D2R
in the cell membrane, it is hypothesized here that D2R is located on the
mitochondria and regulates mitochondrial ROS production.
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The selective removal of damaged mitochondria by autophagy (mitophagy) is the
primary approach to degrade damaged or unwanted mitochondria (Lou et al., 2019).
Mitophagy is crucial for protecting cells against the deleterious effects of damaged
mitochondria (Yamada et al., 2019, Fang et al., 2019). Nevertheless, how D2R
overactivation regulates mitophagy is still unclear. Subsequently, a better
understanding of D2R and mitophagy might provide new therapeutic targets for the
treatment of schizophrenia.
The present study firstly showed that D2R overactivation caused mitochondrial
ultrastructure damage. This observation prompted investigations into the existence
of D2R in neuronal mitochondria. Furthermore, over activating D2R led to
oxidative stress, incomplete mitophagy, and neurite impairment in cultured striatal
neurons.
4.2 Materials and Methods
4.2.1 Antibodies and chemicals
The following reagents were purchased: Quinpirole hydrochloride (Sigma Aldrich,
St Louis, Missouri, USA), anti-MAP2 (1:1,000; Sigma Aldrich), anti-β-actin
(1:5000; Millipore, Bedford, USA), anti-D2R (1:400, Santa Cruz Biotechnology,
CA, USA), and Alexa Fluor 568-conjugated goat anti-rabbit IgG secondary
antibody (1:400; Invitrogen). D2R shRNA was synthesized by GenScript
(GenScript, Hong Kong Ltd).
4.2.2 Striatal neuron culture
The experimental procedures were approved by the Animal Ethics Committee, the
University of Wollongong, Australia (AE18/07), and comply with the Australian
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Code of Practice for the Care and Use of Animals for Scientific Purposes. Striatal
cells were gently dissociated with a plastic pipette after digestion with 0.5% trypsin
(GIBCO, Los Angeles, USA) at 37°C for 30 min. Cells were cultured in Neurobasal
medium (GIBCO) containing B27 supplement (GIBCO) and 20 mM glutamine
(Sigma Aldrich). Cultures were maintained at 37°C in a humidified 5% CO2
incubator.
4.2.3 Cell preparation for cryo-EM
Plasma cleaning of carbon-coated gold TEM grids (Quantifoil NH2A R2/2) was
performed at 2 mA for 10 seconds. Grids were sterilized under UV for 30 min at
room temperature. Grids were carefully washed twice in PBS and coated with 0.1
μg/ml poly-d-lysine for 1 hour at 37 °C. After three PBS washes, striatal neurons
were plated on a final concentration of 3.0 x 105 cells/grid. For cell vitrification,
live striatal neurons were blotted from the backside of the grid for 9 s and rapidly
frozen in liquid nitrogen using a Leica EMGP system.
4.2.4 Image acquisition by Cryo-electron microscopy
Cryo-ET was performed on a Tecnai 20 equipped with a field emission gun and
operated at 200 kV (Thermo Fisher company). Images were captured using either
Explore 3D or SerialEM software on a 4k x 4k camera (Ultrascan from Gatan) and
a Falcon II (FEI, Thermo Fisher) direct electron detector, with a 14 μm pixel size.
Tilt series of mitochondria were acquired covering an angular range of - 60° to +
60° with a 2 to 4 degrees increment. All tilt series were acquired at magnifications
of 25,000× or 29,000 ×, binning 2. Tomograms were manually segmented with the
program AMIRA (FEI).
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4.2.5 HEK-293 cell culture and transfection
HEK-293 cells had no expression of D2R (Thul et al., 2017). In order to study the
effect of over-activation by quinpirole on mitochondria, D2R plasmid was
transfected into HEK-293 cells. HEK-293 cells were grown in Dulbecco's modified
Eagle's medium (DMEM; Life Technologies, Carlsbad, USA) containing 10% fetal
bovine serum and 1% penicillin-streptomycin (Thermo Fisher) at 37°C in 5% CO2.
On the day before transfection, the culture medium was changed to DMEM
containing 10% fetal bovine serum without penicillin-streptomycin. The D2REGFP coding sequences were synthesized by GenScript (GenScript, Hong Kong
Ltd) and sub-cloned into the pcDNA3 vector. Transfection was performed using
Lipofectamine 2000 (Life Technologies) according to the manufacturer's
instructions.
4.2.6 Immunofluorescence
Cells for immunofluorescence were plated on 13 mm coverslips coated with 0.1
μg/ml poly-d-lysine (Sigma Aldrich) at a final concentration of 1.0 × 105 cells/well.
Following treatment, cells were fixed in 4% freshly made formaldehyde,
permeabilized with 0.3% Triton X-100/phosphate-buffered saline (PBS), and
blocked with 5% normal donkey serum (Sigma Aldrich) in PBS. Cells were firstly
immunostained with primary antibodies overnight and then with secondary
antibodies for 2 hours. Cells were viewed using a 63× oil immersion objective on
a TCS SP8 confocal microscope (Leica, Mannheim, Germany).
4.2.7 Western blot
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After treatment, cells were immediately collected in lysis buffer containing NP40
(Sigma Aldrich), protease inhibitor cocktail (Sigma Aldrich), one mM
phenylmethylsulfonyl fluoride (Sigma Aldrich) and 0.5 mM β-glycerophosphate
(Sigma Aldrich). Total protein concentrations were determined by the DC-Assay
(BioRad, Hercules, USA) and detected using a SpectraMax Plus384 absorbance
microplate reader (Molecular Devices, Sunnyvale, USA). The sample protein was
separated on SDS-PAGE gels and then transferred onto polyvinylidene fluoride
(PVDF) membranes. Incubation with primary antibodies was performed overnight
at 4 °C. The blots were then washed and incubated with secondary antibodies for 2
hours at room temperature. For visualization, immunoreactivity was detected using
enhanced chemiluminescence detection reagents. The blots were scanned with an
Amersham Imager 600 RGB (GE Health, Chicago, USA), and densitometry
analysis was performed with ImageQuant TL 8.1 Software (GE Health, Chicago,
USA).
4.2.8 Statistical analysis
GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA) was used to
calculate the significance between groups. For significance analyses of multigroups, p-values were determined by one-way analysis of variance (ANOVA)
followed by Tukey's post hoc corrections. Data were expressed as means ± SEM,
and p < 0.05 was considered statistically different.
4.3 Results
4.3.1 Cryo-ET reveals the abnormal architecture of mitochondrial cristae in
striatal neurons induced by D2R agonist
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The Cryo-ET is an advanced technique to observe the ultrastructure of
mitochondria within its native environment (Tao et al., 2018). To investigate the
effect of D2R overactivation on mitochondrial ultrastructure, this study applied
cryo-ET to analyze the alterations of mitochondria treated with or without D2R
specific agonist quinpirole. Primary striatal neurons were cultured on carboncoated gold grids and vitrified before loading to Cryo-EM. Each tilt series were
reconstructed into a three-dimensional tomogram representing an intact
mitochondrion within its native environment (Figure 1A). In the control group, the
mitochondria showed normal morphology with the intact mitochondrial inner and
outer membrane, as well as canonical cristae folding. However, the mitochondria
of the quinpirole group exhibited remarkable ultrastructural defects compared with
the control group, including a decreased number of folded cristae and length of
cristae (Figure 1B and C). These results suggest that overactivation of D2R could
cause the damage of mitochondrial ultrastructure in primary striatal neurons.
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Figure 4.1 Cryo-ET of mice striatal mitochondria from neurons treated with
or without quinpirole. (A) Tomographic slice from a reconstructed stack of
images taken at different tilt angles of one striatal mitochondrion. The tilt degree is
± 70. Scale bar = 200 nm. (B) Corresponding three-dimensional segmentation of
the mitochondrion from the control and quinpirole group. Quinpirole damaged
striatal mitochondrial ultrastructure with fewer cristae. Scale bar = 20 nm. (C) The
tomographic volume of the mitochondrion from the control and quinpirole group.
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4.3.2 Identification of D2R on neuronal mitochondria
Since this study found that D2R agonist quinpirole impaired the mitochondria
ultrastructure of neurons, I investigated if D2R existed on the neuronal
mitochondria. The primary striatal neurons were co-stained with D2R-Alexa 568
antibody and mitochondrial marker MitoTracker Green. The fluorescent images
showed that the co-localization of D2R and mitochondria distributed not only in
soma but also on the neurite (Figure 2A). The co-localization of D2R with
mitochondria was quantified by measuring the overlapped fluorescence intensities
along neurite. The overlapped signal peaks in fluorescent intensities of D2R and
mitotracker revealed that D2R was co-localized with mitochondria on the neurite
of primary striatal neurons (Figure 2B). To further confirm D2R expresses on
neuronal mitochondria, primary striatal neurons were incubated with D2R shRNA
followed by immunoblot analysis. D2R shRNA transfected into cultured neurons
significantly down-regulated D2R protein level of striatal neurons. (Figure 2C and
D). The expression of D2R was detected in the isolated mitochondria from cultured
striatal neurons. Moreover, D2R shRNA significantly decreased the D2R
expression level in isolated mitochondria (Figure 2E). Taken together, these data
reveal for the first time that D2R is localized in the mitochondria of striatal neurons.
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Figure 4.2 D2R exists in neuronal mitochondria. (A-B) Fluorescent detection of
D2Rs on mitochondria of primary striatal neurons in the wild-type mice. (B) Colocalization analysis of D2R with mitochondria in cultured striatal neurons. The
graph shows the overlap of fluorescence intensity peaks of D2R and mitochondria
along neurite, as indicated in the merged micrograph. Scale bar = 5 µm. Arrows,
specific co-localization of D2R with mitochondria. (C) Representative images of
D2R expression in striatal cell lysate (SCL) and purified mitochondria treated with
or without D2R shRNA. (D-E) Quantification of D2R expression in cultured striatal
cell lysates and isolated mitochondria. N=3, experiments were performed in
triplicate. Data were shown as means ± SEM. * p < 0.05.
4.3.3 D2R overactivation elevates ROS and oxidative stress in striatal neurons
It is reported that the impairment of mitochondrial ultrastructure can lead to the
accumulation of ROS (Jezek et al., 2018). To determine whether quinpirole
increases intracellular ROS level, the primary striatal neurons were firstly treated
with different concentrations of quinpirole followed by staining with DCFDA, an
intracellular ROS marker. Quinpirole increased intracellular ROS level in U shaped
dose-response curves (Figure 3A). Quinpirole at 20, 40, and 60µM increased ROS
with the maximum effects at 20µM, while quinpirole at 10 and 100 µM did not
significantly affect intracellular ROS production (Figure 3B). I further confirmed
that quinpirole at 20 µM increased ROS production in striatal neurons by
visualizing the increased intensity of DCFDA (Figure 3C). The flow cytometric
analysis revealed that the increment of mitochondrial ROS was significant at 20
µM quinpirole, which was similar to the alternation of intracellular ROS (Figure
3D and E). The immunofluorescent images also displayed that quinpirole at 20 µM
increased the intensity of MitoSox Red in the cultured striatal neurons (Figure 3F).
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To investigate the role of mitochondrial D2R in ROS increment, isolated
mitochondria from D2R transfected HEK-293 cells were incubated with 20 µM
quinpirole. Quinpirole treatment displayed the higher fluorescent intensity of
MitoSox compared with the control mitochondria (Figure 3G). MDA, an indicator
of oxidative stress, is produced from the degradation of the cell membrane by
excessive ROS (Massaad and Klann, 2011). This study further found that
quinpirole significantly increased the MDA level (Figure 3H). Thus, these findings
demonstrate that D2R overactivation induced ROS production and oxidative stress
in primary striatal neurons.
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Figure 3 continued
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Figure 4.3 Quinpirole increases reactive oxygen species (ROS) generation in
cultured striatal neurons. (A) The effects of quinpirole on intracellular ROS of
primary striatal neurons. The striatal neurons were treated with quinpirole at
different concentrations, including 0, 10, 20, 40, 60, and 100 μM. Intracellular ROS
was assessed using the DCFDA probe after treatment with quinpirole for 24 h and
quantified by flow cytometry. (B) Flow cytometry of intracellular ROS marked by
DCFDA after primary striatal neurons treated with 20 μM quinpirole. (C)
Representative fluorescent images of intracellular ROS in cultured striatal neurons
treated with 20 μM quinpirole (D) The effects of quinpirole on mitochondrial ROS.
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The neurons were incubated for 24 h with different quinpirole concentrations.
Mitochondrial ROS generation was detected using the MitoSox Red and quantified
by flow cytometry. (E) Flow cytometry of mitochondrial ROS after cultured striatal
neurons treated with 20 μM quinpirole. (F) Representative fluorescent images of
mitochondrial ROS marked by MitoSox in primary striatal neurons treated with 20
μM quinpirole. (G) Quinpirole increases ROS production in isolated mitochondria
from HEK-293 transfected with D2R plasmid. (H) Overactivation of D2R by
quinpirole at 20 μM increases the MDA level in primary striatal neurons. N=3,
experiments were performed in triplicate. Data were shown as means ± SEM. ***
p < 0.001, ** p < 0.01 or * p < 0.05 compared with the controls. Each column
represents the means ± SEM.
4.4.4 D2R overactivation increases autophagosome, but not autolysosomes
Excessive mitochondrial ROS contributes to initiating mitophagy, which eliminates
damaged mitochondria (Schofield and Schafer, 2020). Since I found that quinpirole
treatment increased ROS production, I examined if quinpirole initiates the
autophagy process to clear impaired mitochondria in striatal neurons. During the
process of autophagy, an increase in the conversion rate of LC3-I to LC3-II
indicates enhanced autophagosome formation (Liu et al., 2016). In the quinpiroletreated neurons, not only the LC3-II protein level, but also LC3-II/LC3-I ratio was
significantly increased compared with control group (Figure 4A and B), suggesting
that D2R overactivation led to autophagosome formation. Furthermore, the colocalization of LC3-II with mitochondria marker, Mitotracker Green, was
significantly increased in quinpirole-treated striatal neurons (Figure 4C and D),
confirming abnormal mitochondria are started for autophagic degradation. The
SQSTM1 is degraded with autolysosome formation, indicating autophagy
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completion (Larsen et al., 2010). However, the present study found that SQSTM1
protein expression and immunofluorescent level significantly increased in
quinpirole-treated primary striatal neurons (Figure 4E-G), suggesting inhibition of
autolysosome formation by D2R over-activation. Overall, these results indicated
that D2R overactivation failed to remove damaged mitochondria by mitophagy.
Quinpirole could initiate the formation of autophagosome, but not process to
autolysosome, indicating D2R overactivation results in an incompletion of
mitophagy.
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Figure 4.4 Overactivation of D2R inhibits mitophagy. (A-B) Immunoblot
analysis of LC3-I and LC3-II expression after quinpirole treatment. (C-D)
Representative images and quantification of the co-localization of LC3-II with
mitochondria. Cultured striatal neurons after quinpirole treatment were co-stained
with LC3 II and Mitotracker Green. (E-F) Immunoblot analysis of SQSTM1
expression after quinpirole treatment. (G) Representative immunofluorescent
images of the up-regulation of SQSTM1 in primary striatal neurons. N=3,
experiments were performed in triplicate. Data were shown as means ± SEM. ** p
< 0.01 or * p < 0.05 compared with the controls.
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4.5 D2R overactivation impairs neurite in cultured striatal neurons
It has been reported that dysfunctional mitophagy inhibits neurite growth
(Chakravorty et al., 2019). Since the above study showed that the mitophagy
process was inhibited by D2R overactivation, a further experiment was designed to
determine whether this incomplete mitophagy affects neurite growth. The cultured
striatal neurons were incubated with 20 µM quinpirole for 24 hours, which was
demonstrated to inhibit mitophagy (Figure 4). The result showed that quinpirole
treatment significantly shortened the average length of neurite compared with the
control group (Figure 5 A and B). Moreover, the number of branches was also
significantly decreased in primary striatal neurons treated with quinpirole (Figure
5C). These findings suggest that incomplete mitophagy induced by D2R
overactivation may impair neurite.
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Figure 4.5 D2R overactivation suppresses neurite outgrowth in the primary
striatal neurons. (A) Representative immunofluorescent images for cultured
striatal neurons treated with or without quinpirole at 20 μM for 24 hours. Scale
bar=100 μm. (B) Quantification of neurite length of striatal neurons treated with or
without quinpirole. (C) Quantification of neurite branches of striatal neurons
treated with or without quinpirole. N=3, experiments were performed in triplicate.
Values were shown as means±SEM. *** p < 0.001; **** p < 0.0001.
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Discussion
Over-stimulation of D2R damages the ultrastructure of neuronal mitochondria with
fewer cristae observed in Cryo-ET. D2R specific agonist quinpirole causes
elevation of ROS production and MDA level in cultured striatal neurons. Notably,
SQSTM1 is unable to be degraded after quinpirole treatment, indicating the
mitophagy cannot be completed due to D2R overactivation.
In the current study, our cryo-ET analysis firstly provided strong evidence that
overactivation of D2R damages mitochondrial ultrastructure in primary striatal
neurons. Conventional EM observations have shaped much of our current
knowledge about mitochondrial alterations in schizophrenia (Sorra and Harris,
2000; Harris and Weinberg, 2012). For example, a reduced density of mitochondria
is reported in the striatum and prefrontal cortex of post-mortem brains in
schizophrenia subjects (Uranova et al., 2001). However, ultrastructural studies of
mitochondria are only possible with well-preserved brain tissue within short postmortem intervals. Furthermore, the sample preparation of conventional EM
requires the chemical fixation and embedding process, which are highly possible to
cause damage and shrinkage of mitochondrial structures (Siegmund et al., 2018).
In this study, the live striatal neurons were applied plunge-freezing within seconds,
which significantly improves structural preservation. Frozen striatal neurons on the
grid were directly observed in the Cryo-EM chamber without sectioning. This study
was the first to report that mitochondrial cristae were damaged after D2R was overstimulated in striatal neurons, indicating the critical role of D2R in controlling
mitochondrial integrity. A similar result was also reported that more than 90% of
mitochondria show damaged cristae in dopamine treated human neuroblastoma
cells (Zilocchi et al., 2018). Although D2R was linked to mitochondria function
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before, its role in mitochondrial ultrastructure has not been revealed so far. Further
experiments may need to study the effects of D2R activation on mitochondrial
function, such as ATP synthesis.
This study is the first to demonstrate that D2R was located on the neuronal
mitochondria. Accumulating evidence demonstrates that mitochondria are essential
targets for the actions of dopamine (Burbulla et al., 2017, Chen et al., 2008, Devine
and Kittler, 2018), suggesting that the potential existence of D2R on mitochondria.
This study reported that the existence of D2R immunoblotting signal in isolated
mitochondria of striatal neurons. Importantly, images revealed that D2R is colocalized with mitochondria on the neurite of striatal neurons, suggesting
mitochondrial D2R may have a role in regulating neurite growth. One study showed
that D2R is located around the mitochondrial membrane by transmission electrical
microscopy, although the author did not mention the existence of mitochondrial
D2R (Lane et al., 2012). Taken together, understanding D2R subcellular
localization can actively contribute to receptor function and even disease pathology.
As the new roles of mitochondrial D2R need to be defined, the development of
antipsychotics to both mitochondrial and membrane D2R would produce better
therapeutic outcomes for patients.
The current study provided evidence that the overactivation of D2R by quinpirole
increases cellular ROS production in primary striatal neurons. Although many
studies have already revealed that dopamine causes oxidative stress through
dopamine receptors, the role of D2R in ROS production is not fully explained. A
previous study demonstrated that dopamine shows no effect on ROS production
and huntingtin protein aggregation in striatal neurons cultured from D2R knockout
mice, suggesting that D2R mediates oxidative stress and neurotoxicity (Charvin et
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al., 2005). The mitochondrion is a significant site for ROS production. The
uncontrolled ROS accumulation can further damage mitochondria (Itoh et al.,
2013). The findings confirmed that overactivation of D2R by its specific agonist
increases mitochondrial ROS production in neurons and isolated mitochondria.
Further, this study demonstrated that the excess of mitochondrial ROS induced by
D2R overactivation evoked membrane lipoxidation, indicated by increased MDA.
To my knowledge, this study was the first to reveal the role of D2R in regulating
oxidative stress in striatal neurons. Interestingly, neuronal cultures exposed to
dopamine show oxidative stress as well as a significant decrease in dendritic spines
(Beckhauser et al., 2016). Overactivation of D2R by quinpirole impairs neurite and
synaptic spines in cortical and striatal neurons (Zheng et al., 2018). Consistent with
previous findings, the current study showed that quinpirole at 20 µM decreased
neurite length and branches. The current study implies that excessive ROS
generation may underly the mechanism of neuronal impairment caused by D2R.
Further experiments are required to explore the effects of D2R on the antioxidant
system in the brain.
Mitophagy belonging to a type of autophagy, which aims to eliminate damaged
mitochondria in schizophrenia (Tomoda et al., 2019). Although several published
findings reported that mitophagy is inhibited by antagonizing or down-regulating
D2R, whether over activating D2R will inhibit the mitophagy process is not well
understood (Klein et al., 2019). In the present study, quinpirole un-regulated LC3II expression, suggesting that promoted autophagosome formation at the initial
stage of mitophagy. The increased expression of SQSTM1 suggests that autophagic
clearance or transportation is impaired (Su et al., 2018). In this study, although
autophagosome formation was initiated by D2R overactivation with quinpirole, the
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SQSTM1 was unable to be degraded, suggesting that autophagic clearance was
inhibited in primary striatal neurons. The findings in the present study are supported
by the previous study in which dopamine treatment can also increase the amount of
LC3-II and SQSTM1 in N2a cells leading to the failure of autophagosome
degradation (da Luz et al., 2015). Another study also reported that overactivation
of D2R inhibits autophagy, causing the misfolding and aggregation of the mutated
huntingtin protein in neuroblastoma cells (Vidoni et al., 2016). A recent study
reported that the developing schizophrenia rodent model exhibits an elevated
expression of SQSTM1 in the prefrontal cortex, suggesting that autophagy is
deficient in schizophrenic subjects (Sumitomo et al., 2018). Akira Sawa et. al. also
proposed that elevated SQSTM1 may be a novel mechanism underlying synaptic
functions and cognitive impairment in neurological and neuropsychiatric disorders
(Tomoda et al., 2019). The present study reported that D2R overactivation damaged
neurite growth concomitantly with incompletion of mitophagy. Taken together, our
findings indicate that the inhibited autophagic clearance may play a role in neurite
impairment caused by D2R overactivation.
In conclusion, this study elucidates that D2R overactivation damages mitochondria
and inhibits ROS-mediated mitophagy. The identification of mitochondrial D2R
may provide a new target for treating neurite deficits, and oxidative stress occurred
in schizophrenia.
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Chapter Five
5.1 Overall Discussion and Conclusions
This thesis demonstrates that neurite impairment caused by D2R overactivation is
associated with the increased D2R-DISC1 complex formation and incomplete
mitophagy. Prevention of neurite damage by antipsychotic drugs and cellpenetrating peptide of the D2R-DISC1 complex is also examined in this thesis. This
chapter will begin by reviewing the significant findings from each chapter and then
provide a general discussion of the key findings in my Ph.D. project.
This study firstly discovered the unrecognized signaling pathway where neuronal
impairment caused by D2R overactivation is through D2R-DISC1 complex
formation. The excessive formation of the D2R-DISC1 complex decreased the
phosphorylation of Akt and GSK-3β in cortical neurons. This study further showed
that the downregulation of GSK-3β phosphorylation occurs in cortical pyramidal
neurons. Although both atypical antipsychotic drug aripiprazole and typical
antipsychotic drug haloperidol prevented neurite lesion, aripiprazole displayed
better protection on the neurite length than haloperidol. Using DISC1 mutation
mice, this study also demonstrated that haloperidol and aripiprazole prevented
neurite impairment through DISC1.
This thesis has also contributed with the first description that TAT-D2pep disrupted
the interaction between D2R and DISC1 to prevent neurite lesion, suggesting this
complex would be a potential therapeutic target in treating neurite deficits. Finally,
for the first time, this study reported that mitochondrial D2R existed on the neurite
of primary striatal neurons. This study also demonstrated that mitophagy inhibition
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might be another mechanism underlying membrane and mitochondrial D2R overactivation.
Overall, these findings have provided extensive new knowledge on the mechanism
of D2R in regulating neuroplasticity. We have also addressed several gaps in the
literature by identifying neuronal D2R-DISC1 complex and mitochondrial D2R
that can underlie D2R signaling in neuronal protection. The main findings of this
thesis are summarized in Table 1, Table 2, and Table 3.
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Table 5.1： Summary of main findings in cortical neurons
Quinpirole

Quinpirole

Quinpirole

Quinpirole

Haloperidol

Aripiprazole

Haloperidol

Aripiprazole

Wild type
neuron

Wild type
neuron

Wild type
neuron

DISC1-LI
neuron

DISC1-LI
neuron

DISC1-LI
neuron

Neuronal Morphology
Neurite length in cortical neuron

↓***

↑###

↑###

↓***

↓***

NSC#

NSC#

Neurite Branches in cortical neuron

↓***

↑##

↑###

↓***

↓***

NSC#

Synaptophysin protein in cortical neuron

↓***

↑#

↑#

↑##

↓***

↓***

NSC#

NSC#

PSD-95 protein in cortical neuron

↓***

NSC#

↑###

↓***

↓***

NSC#

NSC#

D2R-DISC1 complex in cortical neuron
D2R Signaling Pathway

↑***

↓###

↓###

NSC

NSC

NSC

NSC

pAkt Ser 473 protein in cortical neuron

↓***

NSC#

↑#

↓***

↓***

NSC#

NSC#

pAkt Thr 308 protein in cortical neuron

↓***

NSC#

↑###

↓***

↓***

NSC#

↑#

Total Akt in cortical neuron

NSC

NSC

#

NSC

NSC

NSC

#

NSC

NSC#

pGSK3β Ser9 in cortical neuron

↓***

NSC#

↑###

↓***

↓***

NSC#

NSC#

pGSK3β Ser9 intensity in cortical pyramidal neuron
Total GSK3β in cortical neuron
GSK3β-DISC1 complex in cortical neuron

↓***
NSC
↓***

NSC

NSC

↓*
NSC

↓***
NSC

Treatment
Parameter

Quinpirole

Quinpirole
DISC1-LI
neuron

D2R-DISC1 Complex

*

#
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*

*

Table 2： Summary of main findings in striatal neurons
Treatment

Quinpirole

Wild type
neuron

Quinpirole
TATD2pep
Wild type
neuron

Quinpirole
TATD2pep-NC
Wild type
neuron

Neuronal Morphology
Neurite length in striatal neuron

↓***

↑###

NSC#

Neurite branches in striatal neuron

↓**

↑###

NSC#

Dendritic spine dendity in striatal neuron

↓**

↑#

NSC#

Synaptophysin density on neurite in striatal neuron

↓***

↑###

NSC#

PSD-95 density on neurite in striatal neuron

↓***

↑###

NSC#

D2R-DISC1 complex in striatal neuron

↑**

↓###

NSC#

Distance between D2R and DISC1 in dendritic spine

↓****

↑####

NSC#

D2R nanocluster diameter

NSC*

NSC*

NSC*

DISC1 nanocluster diameter

NSC*

NSC*

NSC*

Number of D2R nanocluster in dendritic spine

↓**

↑##

NSC#

Number of DISC1 nanocluster in dendritic spine

↓****

↑####

NSC#

pGSK3β Ser9 intensity in striatal interneuron

↓***

↑###

NSC#

NPY in striatal interneuron

↓***

↑###

NSC#

ROS
Mitochondrial cristae length by Cryo-ET
Mitochondrial cristae size by Cryo-ET
Intracellular ROS in striatal neuron
Mitochondrial ROS in striatal neuron
Mitochondrial ROS in isoalted mitochondria
MDA level

↓
↓
↑***
↑***
↑
↑*

Mitophagy
Colocalization of LC3-II and mitochondria
SQSTM1 protein in HEK-293 cell
SQSTM1 intensity in strialtal neuron
Identification of mitochondrial D2R

↑**
↑*
↑
*

Parameter

D2R-DISC1 complex

D2R signalling pathway
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Table 5.3 ： Summary of main findings in HEK-293 cells (D2R and DISC1
plasmid transfected)
Quinpirole

Quinpirole

Quinpirole

Wild type
neuron

TAT-D2pep
Wild type
neuron

TAT-D2pep-NC
Wild type
neuron

Neuronal Morphology
Synaptophysin protein in HEK-293 cell

↓**

↑#

NSC#

PSD-95 protein in HEK-293 cell

↓**

↑#

NSC#

↑***

↓##

NSC#

pGSK3β Ser9 protein in HEK-293 cell

↓***

↑#

NSC#

NPY in HEK-293 cell

↓*

↑#

NSC#

Mitophagy
LC3-I in HEK-293 cell
LC3-II in HEK-293 cell
LC3-II / LC3-I in HEK-293 cell
SQSTM1 protein in HEK-293 cell
Identification of mitochondrial D2R

NSC
↑**
↑**
↑*

Treatment
Parameter

D2R-DISC1 Complex
D2R-DISC1 complex in HEK-293
D2R Signaling Pathway

Abbreviations: D2R:Dopamine D2 receptor; DISC1: Disrupted-in-Schizophrenia
1; LI: Locus impairment; GSK3β: Glycogen synthase kinase 3 beta; Akt: Protein
kinase B (PKB); NPY: Neuropeptide Y; Cryo-ET: Cryo electron tomography;
ROS: Reactive oxygen species; MDA: Malondialdehyde; LC3: Microtubuleassociated proteins 1A/1B light chain 3; SQSTM1: Sequestosome 1; ↑: increase;
↓:decrease; NSC*: no significant change versus control group; NSC#: no
significant change versus quinpirole group; *P< 0.05 versus control; **P< 0.01
versus control; ***P< 0.001 versus control; ****P< 0.0001 versus control; #P<
0.05 versus quinpirole; ##P< 0.01 versus quinpirole; ###P< 0.001 versus
quinpirole; ####P< 0.0001 versus quinpirole;
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5.1.1 Overall Discussion of the Findings
In Chapter 2, it is the first time to demonstrate that D2R overactivation damages
neural networks through the excessive formation of the D2R-DISC1 complex.
Quinpirole induced D2R overactivation has been widely used as a model to study
the mechanisms of schizophrenia and other psychiatric disorders (Kostrzewa et al.,
2016, Stuchlik et al., 2016). The current research reveals that quinpirole
significantly reduces neurite length and branches by increasing the formation of the
D2R-DISC1 complex. It has been previously reported that quinpirole at 100 µM
inhibits neurite outgrowth, while quinpirole at 1 µM mainly promotes axonal
outgrowth, suggesting that D2R activation affects neuronal morphology in a
concentration-dependent manner (Reinoso et al., 1996). In addition, the excessive
formation of the D2R-DISC1 complex decreased the expressions of synaptophysin
and PSD-95, suggesting that the increased D2R-DISC1 complex could weaken
synaptic connections. Chapter 2 also indicates that DISC1 is necessary for neurite
outgrowth by using cultured cortical neurons from DISC1-LI mice. In DISC1-LI
mice, the exons from 1 to 3 in the N-terminal of DISC1 are deleted, which makes
DISC1 lose function and abolishes DISC1 binding with D2R. Thus, I did not
observe significant FRET signals from the D2R-DISC1 complex in cortical neurons
of DISC1-LI mice. It has been demonstrated that DISC1 mutation mice display
enhanced dopamine function associated with psychiatric disorders (Tomoda et al.,
2016). In fact, DISC1 mutation shows no effect on D2R density in the striatum, but
a remarkable rise in the affinity of D2R is observed in rats (Trossbach et al., 2016).
These crucial pieces of evidence explain my study that the Akt-GSK3 signaling
could be suppressed by DISC1-LI induced D2R hyperfunction. In addition, DISC1,
as a scaffolding protein, promotes neuronal development by interacting with other
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signaling molecules, such as GSK3β (Ishizuka et al., 2006, Lipina et al., 2011).
Interestingly, my study demonstrated that quinpirole treatment disassociates the
interaction between DISC1 and GSK3β, leading to more DISC1 binds to D2R in
cortical neurons. Cortical neurons of DISC1-LI mice showed decline in neurite
length and branches, suggesting that the functional domain of DISC1 plays a
critical role in maintaining the neuronal morphology. This study provided novel
proof that dysfunction of the N-terminal of DISC1 or excessive D2R-DISC1
complex results in neurite impairment.
The findings of Chapter 2 further indicate that haloperidol and aripiprazole have
different mechanisms to prevent neurite lesions caused by the excessive D2RDISC1 complex formation. The typical and atypical antipsychotic drugs displayed
different neuroprotective effects in the developing brain (Lieberman et al., 2008).
Clinically, aripiprazole has better efficacy in treating cognitive symptoms than
haloperidol in the onset of schizophrenia (Girgis et al., 2011). Further, haloperidol
has been shown to be cytotoxic to neurons in a concentration-dependent manner
via oxidative stress (Gasso et al., 2012). In the current study, I first identified that
both haloperidol and aripiprazole could block the quinpirole-induced formation of
the D2R-DISC1 complex in cultured cortical neurons. Haloperidol and aripiprazole
restored the neurite length and branches to normal by disassociating the interaction
between D2R and DISC1, suggesting the D2R-DISC1 complex mediates the
neuroprotection by haloperidol and aripiprazole. However, haloperidol showed no
effects on the Akt-GSK3 signaling pathway compared with aripiprazole, suggesting
that haloperidol and aripiprazole affect neuroplasticity via different pathways. It
has been previously reported that aripiprazole but not haloperidol prefers to target
on β-arrestin2 dependent signaling cascades, which leads to primarily affecting the
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activity of GSK3β (Masri et al., 2008, Urs et al., 2017). Importantly, for cultured
cortical neurons from DISC1-LI mice, neither haloperidol nor aripiprazole could
prevent neurite lesion induced by quinpirole. This result indicates that DISC1 is
necessary for haloperidol and aripiprazole to protect neurite, which may provide a
novel target when designing antipsychotic drugs.
In Chapter 3, the study found that D2R interacts with DISC1 within dendritic
spines, which is related to the dendritic spine density of cultured striatal neurons.
A previous study observed a reduction of spine density in a schizophrenia-like
animal model (Solis et al., 2009). Accumulating evidence has indicated that
protein-protein interactions exist in the synapse to affect synaptic functions. It has
been recently reported that the altered interaction between nanomodules within
synapse could influence the size and density of dendritic spines (Hruska et al.,
2018). Here, using STORM imaging, the existence of D2R and DISC1 is firstly
revealed in a nanocluster type instead of a single molecule. Consistent with recent
super-resolution findings, D2R forms oligomers in higher-order in the mouse brain
(Onishi et al., 2018). In addition, the diameter of D2R and DISC1 nanoclusters was
not changed by quinpirole. In the current study, I demonstrated that quinpirole
decreased the distance between D2R and DISC1 nanoclusters to form D2R-DISC1
complex in a single dendritic spine. STORM imaging showed that the complex
formed by D2R and DISC1 could be potential synaptic nanomodules. FRET is a
widely used fluorescence technique to study protein-protein interaction within cells.
In Chapter 2, I used FRET technique to quantify the formation of D2R and DISC1
complex after drugs treatment. This study reports the relationship between the
actual distance of proteins and FRET occurrence, which is the first time that FRET
has been elucidated from a nanoscale perspective. FRET has been proven to be an
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invaluable technique to detect protein interactions in living cells. And most of the
super-resolution microscopy methods are also suitable for living cells. Thus, it is
very interesting to observe at high-resolution where and when the protein
interactions take place by applying FRET in a super-resolution setting. In addition,
this study further revealed that disassociating the D2R-DISC1 complex by TATD2pep restores the dendritic spine density of cultured neurons, indicating that
synaptic D2R-DISC1 complex could be involved in the synaptic formation. Since
dendritic spines have different morphologies (thin, stubby, and mushroom)
associated with learning and memory (Bourne and Harris, 2007), it is interesting to
investigate that the role of synaptic D2R-DISC1 complex in spine morphology.
Similar to the findings in Chapter 2, TAT-D2pep also prevented neurite lesion
induced by the excessive formation of D2R–DISC1 complexes by upregulating
synaptophysin and PSD-95 level. During the process of neurodevelopment,
synaptophysin and PSD-95 serve as essential regulators (Park et al., 2013, Zhang
et al., 2016). Increasing interaction between PSD-95 and DISC1 facilitates
dendritic spine growth (Hayashi-Takagi et al., 2010). As discussed in Chapter 2,
the excessive D2R-DISC1 complex formation decreases the GSK3β-DISC1
interaction. Here, when more DISC1 binds to D2R by quinpirole, less DISC1 may
interact with PSD-95, leading to the reduction of dendritic spine density in cultured
striatal neurons. The results of synaptophysin and PSD-95 in Chapter 2 and Chapter
3 indicates that synaptophysin and PSD-95 mediates the effect of D2R-DISC1
complex on neuronal morphology. Striatal D2R hyperactivity is associated with the
deficits of conditional learning, temporal precision, and working memory in mice
selectively overexpress D2R in the striatum (Kellendonk et al., 2006). Although
schizophrenia patients also have similar cognitive deficits (Gold et al., 2000,
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Carroll et al., 2008, Tek et al., 2002), it may not be appropriate to superimpose the
animal data to humans. More human research is required in this regard. In addition,
findings of Chapter 3 originally reported that D2R overactivation directly decreased
NPY expression by forming excessive D2R-DISC1 complexes, which were
blocked by TAT-D2pep. Previously, it has been reported that D2R overactivation
caused by amphetamine remarkably reduce NPY expression in rat, suggesting that
NPY is regulated by D2R (Kuo, 2003). Here I provided further evidence that D2R
regulates NPY expression through the D2R-DISC1 complex. NPY has been found
mainly existed in GABAergic interneurons and contributes to neuroplasticity and
synaptic communications in the brain (Gotzsche and Woldbye, 2016). Our lab
recently reported that the reduction of NPY expression caused by D2R antagonist
haloperidol in striatal GABAergic interneurons leads to neuronal damage (Hu et al.,
2018). This finding further explains that why haloperidol is not good in protecting
neurite compared with TAT-D2pep even though both haloperidol and TAT-D2pep
can block D2R-DISC1 complex formation. Our lab has previously demonstrated
that the administration of atypical antipsychotic drugs olanzapine remarkably
upregulated mRNA and protein expression levels of NPY in the schizophrenia rat
model (Huang et al., 2006, Lian et al., 2014). The findings of Chapter 3 suggest
that NPY is associated with the neuroprotective effects of TAT-D2pep on neuronal
morphology of cultured striatal neurons.
In Chapter 4, this study revealed that oxidative stress and incomplete mitophagy
are involved in the neurite impairment caused by D2R overactivation in striatal
neurons. This thesis has shown that over activating D2R significantly damaged
neural networks in Chapter 2 and Chapter 3. Since neuronal growth is a highly
energy-demanding process that majorly depends on dendritic mitochondria, I
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assumed that D2R overactivation might result in mitochondrial damage. In the
current study, our cryo-ET analysis firstly provides strong evidence that
overactivation of D2R damaged mitochondrial ultrastructure in primary striatal
neurons. This study was the first to report that mitochondrial cristae were damaged
after D2R was over-stimulated in striatal neurons, indicating the important role of
D2R in controlling mitochondrial integrity. A similar result was also reported that
more than 90% of mitochondria showed damaged cristae in dopamine treated
human neuroblastoma cells (Zilocchi et al., 2018). Further experiments needed to
study the effects of D2R activation on mitochondrial function, like ATP synthesis.
Although many studies have already revealed that dopamine causes oxidative stress
through dopamine receptors, the role of D2R in ROS production is not fully
explained. The mitochondrion is a major site for ROS production, and unrestrained
ROS accumulation can further injure mitochondria. This study confirmed that
overactivation of D2R by its specific agonist increased mitochondrial ROS
production in neurons and isolated mitochondria, indicating hyperdopaminergia
induced ROS generation is conceivably through D2R. To my knowledge, this is the
first time to reveal the role of D2R in regulating oxidative stress in striatal neurons.
Interestingly, neuronal cultures exposed to dopamine show oxidative stress as well
as a significant decrease in dendritic spines (Beckhauser et al., 2016). The current
study implied that excessive ROS generation might underly the mechanism of
neuronal impairment caused by D2R. The results may be responsible for part of the
symptoms of schizophrenia, particularly those involving cognitive functions
(Bitanihirwe and Woo, 2011). At the initial stage of mitophagy, quinpirole
promoted autophagosome formation through an un-regulating LC3-II level. p62 is
the receptor protein that delivers the injured organelles and potentially toxic protein
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aggregates to autophagosomes (Vidoni et al., 2016). The increased expression of
p62 suggests that autophagic clearance or transportation is impaired (Su et al.,
2018). Although the autophagosome formation was initiated, this study reported
the expression of p62 was up regulated following quinpirole treatment, indicating
that autophagic process was inhibited. Consistent with previous study, dopamine
treatment can also increase amount of LC3-II and p62/SQSTM1 in N2a cells
leading to the failure of autophagosome degradation (da Luz et al., 2015). Akira
Sawa et. al. proposed that elevated p62 pathology may serve as a mechanism
underlying synaptic functions and cognitive impairment in neurological and
neuropsychiatric disorders (Tomoda et al., 2019). Taken together, this study
revealed that the inhibited autophagic flux might be a potential consequence of D2
receptor overactivation. Notably, I originally demonstrated that D2R located on the
neuronal mitochondrion and regulated mitochondrial ROS production. Activation
or inhibition of mitochondrial GPCR appears to affect mitochondrial processes
such as ROS production and cell apoptosis (Jong et al., 2018). Importantly, I
visualized that D2R is co-localized with mitochondria on the neurite of striatal
neurons, suggesting mitochondrial D2R may have a role in regulating neurite
growth. Taken together, understanding D2R subcellular localization can strongly
contribute to receptor function and even disease pathology.
5.1.2 Proposed mechanisms of D2R overactivation induced neurite
impairment in different cell models
The main aim of this dissertation is to understand how D2 overactivation would
affect neurite outgrowth and dendritic spine formation. The rationale for this work
is based on evidence that D2R overactivation exists in psychiatric disorder
accompanied by neuronal damage. The findings from the studies provide valuable
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insights for the mechanism through different cell models. As discussed in Chapter
2, the excessive D2R-DISC1 complex formation was firstly reported to inhibit
neurite outgrowth in cortical neurons. The cerebral pathology of schizophrenia has
been studied extensively in recent decades. Deficits in neurite density are
fundamental to the reduction in cerebral volume in early psychosis (Rae et al.,
2017). Findings of Chapter 2 elucidate that the excessive D2R-DISC1 is involved
in the neurite deficits of cortical neurons, suggesting that the D2R-DISC1 could be
a pharmacological target to rescue neurons. Subsequently, the intracellular
signaling pathway of D2R was inhibited by over activating D2R, including reduced
expression of phosphorylated Akt and GSK3β. Interestingly, the reduced
phosphorylation of GSK3β could further disassociate GSK3β-DISC1 complex
leading to more DISC1 binds to D2R. Finally, the excessive D2R-DISC1 complex
caused by D2R overactivation damaged neurite of cortical neurons. To prevent
neurite impairment caused by D2R overactivation, this study further applied typical
antipsychotic drug haloperidol and atypical antipsychotic drug aripiprazole, which
are also D2R antagonists. Surprisingly, although haloperidol and aripiprazole
blocked quinpirole induced D2R-DISC1 formation, they displayed different effects
on Akt-GSK3β signaling and synaptic proteins. Haloperidol had no effects on the
phosphorylation of Akt and GSK3β, suggesting that the D2R independent signaling
pathway is not influenced by typical antipsychotic drug haloperidol. Furthermore,
aripiprazole reversed the quinpirole-induced reduction of synaptophysin and PSD95, while haloperidol had no effect on PSD-95 expression. Studies have shown that
both haloperidol and aripiprazole can stimulate mTOR signaling (Bowling et al.,
2014, Ishima et al., 2012). Activation of mTOR signaling is associated with neurite
outgrowth, branching, and spine density (Kim et al., 2009, Speranza et al., 2015,
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He et al., 2019). Conversely, mTOR inhibitor rapamycin prevents neurite
outgrowth-induced by haloperidol and aripiprazole (Bowling et al., 2014, Ishima et
al., 2012). This may explain the difference in PSD-95 expression between the two
drugs, but the same neurite growth effect observed in this study.
As DISC1 is essential in brain neuroplasticity, this study also examined whether
DISC1 would mediate the effects of haloperidol and aripiprazole on
neuroplasticity. The binding site of D2R and DISC1 is abolished in DISC1-LI mice.
Notably, neither haloperidol nor aripiprazole protected neurite of cultured DISC1LI cortical neurons, displaying no alternations in Akt-GSK3β signaling and
synaptic proteins compared with quinpirole treated group. This study for the first
time demonstrates that haloperidol and aripiprazole protect neuroplasticity via
DISC1, which may provide further evidence for designing novel antipsychotic
drugs. Further, in vivo experiments need to be performed to study whether
haloperidol and aripiprazole could ameliorate cognitive decline in the
schizophrenia animal model by decreasing the D2R-DISC1 complex.
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Figure 5.1 Proposed mechanisms of D2R-DISC1 induced neurite impairment
in cultured cortical neurons. In cortical neurons of wild type mice, ①D2R

overactivation induced by quinpirole increased the D2R-DISC1 complex
formation. Both haloperidol and aripiprazole blocked the D2R-DISC1 complex
formation induced by quinpirole. Administration of 100 µM quinpirole for 48 hours
significantly inhibited ②Akt phosphorylation on Thr308 and Ser473 and

③GSK3β phosphorylation on Ser9. ④The declined phosphorylation of GSK3β
Ser9 then led to disassociation of GSK3β-DISC1 complex, which lets more DISC1

bind to D2R. Aripiprazole and haloperidol displayed different effects on Akt-GSK3
signaling. Aripiprazole prevented the reduction of ②Akt phosphorylation on
Thr308 and Ser473 and ③GSK3β phosphorylation on Ser9. The elevated

formation of the D2R-DISC1 complex caused by quinpirole significantly inhibited
the expression of ⑤synaptophysin and ⑥PSD-95. Aripiprazole reversed the

quinpirole-induced reduction of ⑤synaptophysin and ⑥PSD-95, while

haloperidol has no effect on PSD-95 expression. Finally, the excessive formation
of the D2R-DISC1 complex caused by quinpirole significantly decreased ⑦neurite

length and ⑧branches in cortical neurons. In cortical neurons of DISC1-LI mice,

⑨the D2R-DISC1 complex formation is abolished because the binding site on
DISC1 is deleted. Quinpirole exacerbates the decreased phosphorylation of ⑩Akt
on Thr308 and Ser473 and ⑪GSK3β on Ser9 compared with wild type neurons.

Aripiprazole and haloperidol were unable to fully reverse the phosphorylation of
⑩Akt on Thr308 and Ser473 and ⑪GSK3β on Ser9. Further, both haloperidol

and aripiprazole failed to change the decreased expression of synaptic proteins
⑫synaptophysin and ⑬PSD-95 caused by quinpirole. Finally, haloperidol and

aripiprazole failed to rescue ⑭neurite impairment in cortical neurons of DISC1-LI
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mice.
Abbreviations: Quin: quinpirole at 100 µM; Halo: haloperidol at 10 µM; Ari:
aripiprazole at 10 µM. D2R: dopamine D2 receptor; SYN: synaptophysin; DISCLI: DISC1 locus impairment. Blue arrow: quinpirole treatment; Red arrow:
pretreatment of haloperidol in the presence of quinpirole at 10 µM. Green arrow:
pretreatment of aripiprazole in the presence of quinpirole at 10 µM. Yellow arrow:
cortical neurons of DISC1 locus impairment mice.
It has been demonstrated that D2R abundantly expresses in the striatum, which
makes striatal D2R is the major target for antipsychotic drugs. Based on the
findings in Chapter 1, the thesis further investigated the role of D2R-DISC1 in the
synaptogenesis of striatal neurons by using super-resolution microscopy. Notably,
this thesis firstly identified that the interaction between D2R and DISC1 exited in
a single dendritic spine of striatal neurons, suggesting that the synaptic D2R-DISC1
complex could be a novel nanomodule consisting of synaptic architecture. As
discussed in Chapter 2, I used FRET technology to demonstrate whether the D2RDISC1 complex was formed, which showed the distance of D2R and DISC1 is less
than 10 nm. In this study, the STORM images quantified the actual distance of D2R
and DISC1 nanoclusters in synapses, which provides the possibility of using a
super-resolution technique to quantify fluorescent-based FRET. The cellpenetrating peptide, TAT-D2pep, targeted explicitly on separating excessive
synaptic D2R-DISC1 complex induced by quinpirole. The findings from STORM
also expanded our understandings that D2R and DISC1 existed in dendritic spines
with nanoclusters manner instead of single molecular. The density of D2R and
DISC1 nanoclusters were decreased by quinpirole, which was prevented by cellpenetrating peptide TAT-D2pep. Further, this study reported that the excessive
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synaptic D2R-DISC1 complex was accompanied by a reduction in dendritic spine
density. TAT-D2pep protected dendritic spines, suggesting that the D2R-DISC1
complex plays an important role in regulating spine formation. In addition, this
study for the first time reveals that the protective effects of TAT-D2pep on neurite
is through GSK3β-NPY signaling in striatal interneurons. Accumulating evidence
indicated that D2R is involved in regulating the mitophagy process in several
diseases, like Parkinson’s disease. Here, the findings showed that D2R
overactivation significantly increased intracellular and mitochondrial ROS levels.
Although the excessive ROS production initiated autophagosome formation, the
formation of autolysosome was inhibited due to over activating D2R. Interestingly,
D2R was firstly identified on the mitochondrial membrane. Overactivation of
mitochondrial D2R led to the decreased number of folded cristae and length of
cristae, which provides novel targets for preventing mitochondrial damage.
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Figure 5.2 Proposed mechanisms of D2R-DISC1 induced neurite impairment
in cultured striatal neurons. In striatal neurons, ①the D2R-DISC1 complex
formation was significantly increased by quinpirole at 10 µM on neurite and soma.

Preincubation with TAT-D2pep uncoupled excessive D2R-DISC1 complex
induced by quinpirole. The excessive D2R-DISC1 complex formation induced by
quinpirole then decreased the ②GSK3β phosphorylation on Ser9 and ③NPY,

while TAT-D2pep reversed the declined GSK3β phosphorylation and NPY in

striatal interneurons. The inhibited GSK3β signaling pathway then led to a
reduction in the intensity of ④synaptophysin and ⑤PSD-95 on neurite, which was

reversed by TAT-D2pep. TAT-D2pep protected neurite growth by disrupting the
D2R-DISC1 complex, increasing GSK3β signaling, and synaptic protein
expression. In a single dendritic spine of cultured striatal neurons, the interaction
between D2R and DISC1 was observed by using super-resolution microscopy
(STORM). ⑥STORM images revealed that the distance between D2R and DISC1
nanoclusters was reduced in dendritic spines after quinpirole treatment. TAT-

D2pep increased the distance between D2R and DISC1 nanoclusters in the presence
of quinpirole. In addition, the density of ⑦D2R and ⑧DISC1 nanoclusters were

decreased after the D2R-DISC1 complex was excessively formed by quinpirole in
dendritic spines. TAT-D2pep restored the density of D2R and DISC1 nanoclusters
by decreasing the interaction between D2R and DISC1. Further, the excessive
formation of the D2R-DISC1 complex in single dendritic spines significantly
reduced the ⑨spine density, which was reversed by TAT-D2pep. In mitochondria
of cultured striatal neurons. In addition, D2R overactivation significantly increased
⑩the intracellular ROS level. Although the excessive ROS production initiated

⑪autophagosome formation (LC3 II / LC3 I), ⑫the formation of autolysosome
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(SQSTM1) was inhibited due to over activating D2R. The incomplete mitophagy
failed to eliminate ROS leading to ⑬MDA accumulation within striatal neurons.

⑭The excessive D2R-DISC1 complex formation and incomplete mitophagy
impaired neurite outgrowth. ⑮D2R was firstly identified on the mitochondrial

membrane. Overactivation of D2R led to ⑯mitochondrial ROS production,
resulting in ⑰ a decreased number of folded cristae and length of cristae. Thus,
D2R-DISC1 complex induced oxidative stress may also involve in neurite lesion.

Abbreviation: Quin: quinpirole at 10 µM; TAT-D2: TAT-D2pep at 10 µM. ROS:
reactive oxygen species. Blue arrow: quinpirole treatment; Orange arrow:
Pretreatment of TAT-D2pep in the presence of quinpirole at 10 µM.
To specifically determine which signaling molecule is influenced by the D2RDISC1 complex, this study constructed a HEK-293 cell model that was transfected
with D2R and DISC1 plasmids. Consistent with the findings in cortical neurons
and striatal neurons, D2R overactivation induced by quinpirole significantly
increased the formation of the D2R-DISC1 complex. D2R antagonist haloperidol
and cell-penetrating peptide TAT-D2pep disrupted the excessive formation of the
D2R-DISC1 complex. Increased interaction of D2R and DISC1 induced by
quinpirole further decreased the GSK3β phosphorylation on Ser 9. The decreased
GSK3β phosphorylation induced by D2R-DISC1 interaction was reversed by TATD2pep but not D2R antagonist haloperidol. The expression of NPY was inhibited
by quinpirole, which can be restored to the control level by TAT-D2pep. Finally,
the expressions of synaptophysin and PSD-95 were reduced by the excessive D2RDISC1 complex, which was restored to the control level by TAT-D2pep. In HEK293 cells, I also reported that the excessive D2R-DISC1 complex resulted in
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incomplete mitophagy by failing to degrade SQSTM1.

Figure 5.3 TAT-D2pep reverses the reductions of synaptic proteins and
autophagy induced by D2R-DISC1 in HEK-293 cells. In HEK-293 cells, the
D2R-eGFP and DISC1 mCherry constructs were transfected to generate a cell
model for studying the interaction between D2R and DISC1. ①D2R overactivation
induced by quinpirole increased the formation of D2R-DISC1 complex more than
three folds. The excessive formation of the D2R-DISC1 complex was blocked by
D2R antagonist haloperidol and cell-penetrating peptide TAT-D2pep. Further,
quinpirole failed to induce D2R-DISC1 complex formation when the specific
binding site on D2R was deleted. ②Increased D2R-DISC1 complex induced by

quinpirole further decreased the GSK3β phosphorylation on Ser 9. The decreased

GSK3β phosphorylation caused by the D2R-DISC1 complex was reversed by TATD2pep but not D2R antagonist haloperidol. ③The expression of NPY was

inhibited by quinpirole, which can be restored to the control level by TAT-D2pep.
138

Finally, the expressions of ④synaptophysin and ⑤PSD-95 were reduced by the

excessive D2R-DISC1 complex, which was restored to the control level by TATD2pep.

⑥ Although the excessive D2R-DISC1 initiated autophagosome

formation (LC3 II / LC3 I), ⑦the formation of autolysosome (SQSTM1) was
inhibited due to the excessive D2R-DISC1 complex.

Abbreviation: Quin: quinpirole at 10 µM; TAT-D2: TAT-D2pep at 10 µM. Blue
arrow: quinpirole treatment; Orange arrow: Pretreatment of TAT-D2pep in the
presence of quinpirole at 10 µM.
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5.1 Recommendations for Future Research
According to the findings, the recommendations are made as follows:
1. This study investigated the effect of TAT-D2pep on neuroprotection using cellbased models only. Although the results were promising, a preclinical trial will be
necessary to verify the neuroprotective effect and study the consequence of
behavioral changes in rodents after TAT-D2pep treatment. It is recommended to
use the rodent models with dopamine hyperactivity relevant to schizophrenia
together with appropriate controls.
2. Dendritic spines are highly dynamic, which are re-categorized by superresolution microscopy into two major types: thin and mushroom. Thin spines are
more flexible ‘learning spines,’ whereas mushroom spines are more stable
‘memory spines’ (Bourne and Harris, 2007). Although we were the first to link
D2R-DISC1 complex to dendritic pine formation in this study, it is still unknown
whether this complex will influence thin and mushroom spine dynamics.
3. It is interesting to observe D2R locates on mitochondrion. Due to the access to
D2R knockout mice and time limitation, we were unable to clarify the existence of
mitochondrial D2R in vivo. A future study could further investigate the D2R is
located on the inner or outer membrane of mitochondrion by using the Cryo-EM
technique.
4. Last, the measurements of neurite length in this study are from a two-dimensional
surface, which may not fully reflect how neurons may grow in the actual
environment. Thus, the three-dimensional culturing device may be applied in future
research to confirm these neuroprotective effects.
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5. It is well known that excessive dopamine activity can cause an onset of
psychosis. This is reported in several psychiatric disorders, including
schizophrenia, bipolar disorder at manic state, obsessive-compulsive disorder, and
some drug abuses. Based on my study, it is likely that hyperdopaminergic activity
will cause an abnormal D2R-DISC1 complex; however, such assumptions will
require further studies to prove.
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5.2 Conclusion
Neurite deficits result in the alternation in neural connection and psychotic
symptoms in psychiatric disorders. Here the findings of the present thesis have
demonstrated that the excessive D2R-DISC1 complex caused by D2R
overactivation had remarkable effects on the neuroplasticity of cortical and striatal
neurons. The abnormal D2R-DISC1 complex caused downregulation of
phosphorylated Akt and GSK3β, synaptic proteins, and NPY in neurons. This study
also provided evidence that haloperidol showed less protection on neurite than
aripiprazole, mainly because haloperidol had no effects on the D2R intracellular
signaling pathway. The DISC1-LI mutant made the neuroprotective effects of
haloperidol and aripiprazole invalid. The new antipsychotic peptide TAT-D2pep
was demonstrated to protect neuroplasticity and synapse. This study initially
demonstrated that D2R existed on the mitochondrial membrane of neurons.
Overactivation of cellular and mitochondrial D2R significantly increased ROS
production, which resulted in incomplete mitophagy. Taken together, the D2RDISC1 complex and mitochondrial D2R might be potential therapeutic targets for
treating neurite deficits in schizophrenia patients.
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